141 results on '"Bowang Chen"'
Search Results
2. Deciphering complex antibiotic resistance patterns in Helicobacter pylori through whole genome sequencing and machine learning
- Author
-
Jianwei Yu, Yan Jia, Qichao Yu, Lan Lin, Chao Li, Bowang Chen, Pingyu Zhong, Xueqing Lin, Huilan Li, Yinping Sun, Xuejing Zhong, Yuqi He, Xiaoyun Huang, Shuangming Lin, and Yuanming Pan
- Subjects
antimicrobial resistance (AMR) ,Helicobactor pylori ,genomic sequencing data ,machine learning methods ,molecular mechanism ,Microbiology ,QR1-502 - Abstract
IntroductionHelicobacter pylori (H.pylori, Hp) affects billions of people worldwide. However, the emerging resistance of Hp to antibiotics challenges the effectiveness of current treatments. Investigating the genotype-phenotype connection for Hp using next-generation sequencing could enhance our understanding of this resistance.MethodsIn this study, we analyzed 52 Hp strains collected from various hospitals. The susceptibility of these strains to five antibiotics was assessed using the agar dilution assay. Whole-genome sequencing was then performed to screen the antimicrobial resistance (AMR) genotypes of these Hp strains. To model the relationship between drug resistance and genotype, we employed univariate statistical tests, unsupervised machine learning, and supervised machine learning techniques, including the development of support vector machine models.ResultsOur models for predicting Amoxicillin resistance demonstrated 66% sensitivity and 100% specificity, while those for Clarithromycin resistance showed 100% sensitivity and 100% specificity. These results outperformed the known resistance sites for Amoxicillin (A1834G) and Clarithromycin (A2147), which had sensitivities of 22.2% and 87%, and specificities of 100% and 96%, respectively.DiscussionOur study demonstrates that predictive modeling using supervised learning algorithms with feature selection can yield diagnostic models with higher predictive power compared to models relying on single single-nucleotide polymorphism (SNP) sites. This approach significantly contributes to enhancing the precision and effectiveness of antibiotic treatment strategies for Hp infections. The application of whole-genome sequencing for Hp presents a promising pathway for advancing personalized medicine in this context.
- Published
- 2024
- Full Text
- View/download PDF
3. Associations of long-term fine particulate matter exposure with all-cause and cause-specific mortality: results from the ChinaHEART projectResearch in context
- Author
-
Wei Li, Aoxi Tian, Yu Shi, Bowang Chen, Runqing Ji, Jinzhuo Ge, Xiaoming Su, Boxuan Pu, Lubi Lei, Runmei Ma, Qing Wang, Jie Ban, Lijuan Song, Wei Xu, Yan Zhang, Wenyan He, Hao Yang, Xi Li, Tiantian Li, and Jing Li
- Subjects
Air pollution ,PM2.5 ,All-cause mortality ,Cause-specific mortality ,Concentrationresponse functions ,Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: The chronic effects of fine particulate matter (PM2.5) at high concentrations remains uncertain. We aimed to examine the relationship of long-term PM2.5 exposure with all-cause and the top three causes of death (cardiovascular disease [CVD], cancer, and respiratory disease), and to analyze their concentration-response functions over a wide range of concentrations. Methods: We enrolled community residents aged 35–75 years from 2014 to 2017 from all 31 provinces of the Chinese Mainland, and followed them up until 2021. We used a long-term estimation dataset for both PM2.5 and O3 concentrations with a high spatiotemporal resolution to assess the individual exposure, and used Cox proportional hazards models to estimate the associations between PM2.5 and mortalities. Findings: We included 1,910,923 participants, whose mean age was 55.6 ± 9.8 years and 59.4% were female. A 10 μg/m3 increment in PM2.5 exposure was associated with increased risk for all-cause death (hazard ratio 1.02 [95% confidence interval 1.012–1.028]), CVD death (1.024 [1.011–1.037]), cancer death (1.037 [1.023–1.052]), and respiratory disease death (1.083 [1.049–1.117]), respectively. Long-term PM2.5 exposure nonlinearly related with all-cause, CVD, and cancer mortalities, while linearly related with respiratory disease mortality. Interpretation: The overall effects of long-term PM2.5 exposure on mortality in the high concentration settings are weaker than previous reports from settings of PM2.5 concentrations < 35 μg/m³. The distinct concentration-response relationships of CVD, cancer, and respiratory disease mortalities could facilitate targeted public health efforts to prevent death caused by air pollution. Funding: The Chinese Academy of Medical Sciences Innovation Fund for Medical Science, the National High Level Hospital Clinical Research Funding, the Ministry of Finance of China and National Health Commission of China, the 111 Project from the Ministry of Education of China.
- Published
- 2023
- Full Text
- View/download PDF
4. Influence of Socioeconomic Gender Inequality on Sex Disparities in Prevention and Outcome of Cardiovascular Disease: Data From a Nationwide Population Cohort in China
- Author
-
Yunfeng Wang, Aoxi Tian, Chaoqun Wu, Jiapeng Lu, Bowang Chen, Yang Yang, Xiaoyan Zhang, Xingyi Zhang, Jianlan Cui, Wei Xu, Lijuan Song, Weihong Guo, Runsi Wang, Xi Li, and Shengshou Hu
- Subjects
cardiovascular disease ,prevention ,sex disparity ,socioeconomic ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background Knowledge gaps remain in how gender‐related socioeconomic inequality affects sex disparities in cardiovascular diseases (CVD) prevention and outcome. Methods and Results Based on a nationwide population cohort, we enrolled 3 737 036 residents aged 35 to 75 years (2014–2021). Age‐standardized sex differences and the effect of gender‐related socioeconomic inequality (Gender Inequality Index) on sex disparities were explored in 9 CVD prevention indicators. Compared with men, women had seemingly better primary prevention (aspirin usage: relative risk [RR], 1.24 [95% CI, 1.18–1.31] and statin usage: RR, 1.48 [95% CI, 1.39–1.57]); however, women's status became insignificant or even worse when adjusted for metabolic factors. In secondary prevention, the sex disparities in usage of aspirin (RR, 0.65 [95% CI, 0.63–0.68]) and statin (RR, 0.63 [95% CI, 0.61–0.66]) were explicitly larger than disparities in usage of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers (RR, 0.88 [95% CI, 0.84–0.91]) or β blockers (RR, 0.67 [95% CI, 0.63–0.71]). Nevertheless, women had better hypertension awareness (RR, 1.09 [95% CI, 1.09–1.10]), similar hypertension control (RR, 1.01 [95% CI, 1.00–1.02]), and lower CVD mortality (hazard ratio, 0.46 [95% CI, 0.45–0.47]). Heterogeneities of sex disparities existed across all subgroups. Significant correlations existed between regional Gender Inequality Index values and sex disparities in usage of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers (Spearman correlation coefficient, r=−0.57, P=0.0013), hypertension control (r=−0.62, P=0.0007), and CVD mortality (r=0.45, P=0.014), which remained significant after adjusting for economic factors. Conclusions Notable sex disparities remain in CVD prevention and outcomes, with large subgroup heterogeneities. Gendered socioeconomic factors could reinforce such disparities. A sex‐specific perspective factoring in socioeconomic disadvantages could facilitate more targeted prevention policy making.
- Published
- 2023
- Full Text
- View/download PDF
5. A novel scatterplot-based method to detect copy number variation (CNV)
- Author
-
Jia-Lu Qiao, Rebecca T. Levinson, Bowang Chen, Stefan T. Engelter, Philipp Erhart, Brady J. Gaynor, Patrick F. McArdle, Kristina Schlicht, Michael Krawczak, Martin Stenman, Arne G. Lindgren, John W. Cole, and Caspar Grond-Ginsbach
- Subjects
copy number variation (CNV) ,pennCNV ,scatterplot ,filtering ,quality control ,Genetics ,QH426-470 - Abstract
Objective: Most methods to detect copy number variation (CNV) have high false positive rates, especially for small CNVs and in real-life samples from clinical studies. In this study, we explored a novel scatterplot-based method to detect CNVs in microarray samples.Methods: Illumina SNP microarray data from 13,254 individuals were analyzed with scatterplots and by PennCNV. The data were analyzed without the prior exclusion of low-quality samples. For CNV scatterplot visualization, the median signal intensity of all SNPs located within a CNV region was plotted against the median signal intensity of the flanking genomic region. Since CNV causes loss or gain of signal intensities, carriers of different CNV alleles pop up in clusters. Moreover, SNPs within a deletion are not heterozygous, whereas heterozygous SNPs within a duplication show typical 1:2 signal distribution between the alleles. Scatterplot-based CNV calls were compared with standard results of PennCNV analysis. All discordant calls as well as a random selection of 100 concordant calls were individually analyzed by visual inspection after noise-reduction.Results: An algorithm for the automated scatterplot visualization of CNVs was developed and used to analyze six known CNV regions. Use of scatterplots and PennCNV yielded 1019 concordant and 108 discordant CNV calls. All concordant calls were evaluated as true CNV-findings. Among the 108 discordant calls, 7 were false positive findings by the scatterplot method, 80 were PennCNV false positives, and 21 were true CNVs detected by the scatterplot method, but missed by PennCNV (i.e., false negative findings).Conclusion: CNV visualization by scatterplots allows for a reliable and rapid detection of CNVs in large studies. This novel method may thus be used both to confirm the results of genome-wide CNV detection software and to identify known CNVs in hitherto untyped samples.
- Published
- 2023
- Full Text
- View/download PDF
6. Association of Leisure-Time Physical Activity and Mortality Risk in High Cardiovascular Risk Population with and without Left Ventricular Hypertrophy
- Author
-
Huijun Jin, Xiulin Wang, Hao Dai, Aoxi Tian, Bowang Chen, Chaoqun Wu, Xiaoyan Zhang, Jianlan Cui, Yi Wu, Xi Li, and Xin Zheng
- Subjects
leisure-time physical activity ,left ventricular hypertrophy ,cardiac remodeling ,cardiovascular risks factors ,metabolic equivalent ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background: Increased leisure-time physical activity (LTPA) is linked with decreased mortality risk, while also with increased left ventricular mass, which may induce left ventricular hypertrophy (LVH). We investigated whether LVH modifies the association between higher LTPA and lower mortality risk in population at high cardiovascular risk. Methods: In a prospective national cohort, we used the left ventricular mass/body surface area (LVM/BSA) method to define LVH. Baseline LTPA was self-reported and divided into: low (
- Published
- 2023
- Full Text
- View/download PDF
7. BNIP3 Upregulation Characterizes Cancer Cell Subpopulation With Increased Fitness and Proliferation
- Author
-
Yanyan Zhu, Bowang Chen, Junya Yan, Wendi Zhao, Pengli Dou, Na Sun, Yaokai Wang, and Xiaoyun Huang
- Subjects
BNIP3 ,ScRNA-seq ,mitophagy ,systems biology ,cancer heterogeneity ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
BNIP3 is a BH3-only protein with both pro-apoptotic and pro-survival roles depending on the cellular context. It remains unclear how BNIP3 RNA level dictates cell fate decisions of cancer cells. Here, we undertook a quantitative analysis of BNIP3 expression and functions in single-cell datasets of various epithelial malignancies. Our results demonstrated that BNIP3 upregulation characterizes cancer cell subpopulations with increased fitness and proliferation. We further validated the upregulation of BNIP3 in liver cancer 3D organoid cultures compared with 2D culture. Taken together, the combination of in silico perturbations using public single-cell datasets and experimental cancer modeling using organoids ushered in a new approach to address cancer heterogeneity.
- Published
- 2022
- Full Text
- View/download PDF
8. Genome-wide analysis of DNA methylation and risk of cardiovascular disease in a Chinese population
- Author
-
Yan Gao, Huifang Pang, Bowang Chen, ChaoQun Wu, Yanping Wang, Libo Hou, Siming Wang, Dianjianyi Sun, and Xin Zheng
- Subjects
EWAS ,DNA methylation ,CVD ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Systemic studies of association of genome-wide DNA methylated sites with cardiovascular disease (CVD) in prospective cohorts are lacking. Our aim was to identify DNA methylation sites associated with the risk of CVD and further investigate their potential predictive value in CVD development for high-risk subjects. Methods We performed an epigenome-wide association study (EWAS) to identify CpGs related to CVD development in a Chinese population.We adopted a nested case–control design based on data from China PEACE Million Persons Project. A total of 83 cases who developed CVD events during follow-up and 83 controls who were matched with cases by age, sex, BMI, ethnicity, medications treatment and behavior risk factors were included in the discovery stage. Genome-wide DNA methylation from whole blood was detected using Infinium Human Methylation EPIC Beadchip (850 K). For significant CpGs [FDR(false discovery rate)
- Published
- 2021
- Full Text
- View/download PDF
9. Comparative Study on Clear Specimen Strength and Member Strength of Side-Pressure Laminated Bamboo
- Author
-
Danping Gao, Bowang Chen, Liu Wang, Chunan Tang, and Ping Yuan
- Subjects
Engineering (General). Civil engineering (General) ,TA1-2040 - Abstract
Side-pressure laminated bamboo (LB) made from heat-modified, fast-growing bamboo is introduced in this document. As a relatively new type of bamboo composite fabricated by bamboo strips, side-pressure LB has some favorable mechanical properties, such as thermal insulation, light mass, high strength, and earthquake resistance. To promote the application of side-pressure LB in structural engineering, according to the test standards for timber, the mechanical properties of bamboo, including tensile strength parallel to the grain, compressive strength parallel to the grain, bending strength and bending modulus, and shear strength parallel to the grain, were obtained by testing clear bamboo. Meanwhile, the bending and shear tests were performed on full-sized beams of side-pressure LB. Comparing the strength of clear bamboo and full-sized bamboo beams under bending and shear, explore the effect of size on bending and shear strength. The results demonstrate that the size effect has a significant influence on the bending strength, and the bending strength decreases clearly with the increase of the span of member; the shear strength is mainly affected by the shear area and decreases with the increase of the shear area. Based on the measured indicators of shear strength, a formula suitable for converting the shear strength of clear bamboo to full-sized bamboo beam is proposed. And the recommended design strengths of bamboo are given by using the limit state method, which provides a design basis for the engineering application of bamboo.
- Published
- 2022
- Full Text
- View/download PDF
10. The copy number variation and stroke (CaNVAS) risk and outcome study.
- Author
-
John W Cole, Taiwo Adigun, Rufus Akinyemi, Onoja Matthew Akpa, Steven Bell, Bowang Chen, Jordi Jimenez Conde, Uxue Lazcano Dobao, Israel Fernandez, Myriam Fornage, Cristina Gallego-Fabrega, Christina Jern, Michael Krawczak, Arne Lindgren, Hugh S Markus, Olle Melander, Mayowa Owolabi, Kristina Schlicht, Martin Söderholm, Vinodh Srinivasasainagendra, Carolina Soriano Tárraga, Martin Stenman, Hemant Tiwari, Margaret Corasaniti, Natalie Fecteau, Beth Guizzardi, Haley Lopez, Kevin Nguyen, Brady Gaynor, Timothy O'Connor, O Colin Stine, Steven J Kittner, Patrick McArdle, Braxton D Mitchell, Huichun Xu, and Caspar Grond-Ginsbach
- Subjects
Medicine ,Science - Abstract
Background and purposeThe role of copy number variation (CNV) variation in stroke susceptibility and outcome has yet to be explored. The Copy Number Variation and Stroke (CaNVAS) Risk and Outcome study addresses this knowledge gap.MethodsOver 24,500 well-phenotyped IS cases, including IS subtypes, and over 43,500 controls have been identified, all with readily available genotyping on GWAS and exome arrays, with case measures of stroke outcome. To evaluate CNV-associated stroke risk and stroke outcome it is planned to: 1) perform Risk Discovery using several analytic approaches to identify CNVs that are associated with the risk of IS and its subtypes, across the age-, sex- and ethnicity-spectrums; 2) perform Risk Replication and Extension to determine whether the identified stroke-associated CNVs replicate in other ethnically diverse datasets and use biomarker data (e.g. methylation, proteomic, RNA, miRNA, etc.) to evaluate how the identified CNVs exert their effects on stroke risk, and lastly; 3) perform outcome-based Replication and Extension analyses of recent findings demonstrating an inverse relationship between CNV burden and stroke outcome at 3 months (mRS), and then determine the key CNV drivers responsible for these associations using existing biomarker data.ResultsThe results of an initial CNV evaluation of 50 samples from each participating dataset are presented demonstrating that the existing GWAS and exome chip data are excellent for the planned CNV analyses. Further, some samples will require additional considerations for analysis, however such samples can readily be identified, as demonstrated by a sample demonstrating clonal mosaicism.ConclusionThe CaNVAS study will cost-effectively leverage the numerous advantages of using existing case-control data sets, exploring the relationships between CNV and IS and its subtypes, and outcome at 3 months, in both men and women, in those of African and European-Caucasian descent, this, across the entire adult-age spectrum.
- Published
- 2021
- Full Text
- View/download PDF
11. Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data
- Author
-
Yanyan Zhu, Shundong Cang, Bowang Chen, Yue Gu, Miaomiao Jiang, Junya Yan, Fengmin Shao, and Xiaoyun Huang
- Subjects
ccRCC ,RNA-Seq ,transcription factor ,Systems Biology ,personalized oncology ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Clear cell renal cell carcinoma represents the most common type of kidney cancer. Precision medicine approach to ccRCC requires an accurate stratification of patients that can predict prognosis and guide therapeutic decision. Transcription factors are implicated in the initiation and progression of human carcinogenesis. However, no comprehensive analysis of transcription factor activity has been proposed so far to realize patient stratification. Here we propose a novel approach to determine the subtypes of ccRCC patients based on global transcription factor activity landscape. Using the TCGA cohort dataset, we identified different subtypes that have distinct up-regulated biomarkers and altered biological pathways. More important, this subtype information can be used to predict the overall survival of ccRCC patients. Our results suggest that transcription factor activity can be harnessed to perform patient stratification.
- Published
- 2020
- Full Text
- View/download PDF
12. Experimental Study on Axial Compression Behavior of Masonry Columns’ Strengthening with Bamboo Scrimber Bar Mesh Mortar Layer
- Author
-
Hongyao Liu, Min Lei, and Bowang Chen
- Subjects
Engineering (General). Civil engineering (General) ,TA1-2040 - Abstract
We propose a new method to strengthen structural masonry. To study on the axial compression behavior of masonry columns’ strengthening with a bamboo scrimber bar mesh mortar layer, axial compression tests of twelve masonry columns have been completed: nine strengthened columns and three unstrengthened columns. The failure process, bearing capacity, and failure mode are carried out. The strengthening method of bamboo scrimber bar mesh mortar layer permits the upgrade of the columns’ bearing capacity. The effects of bamboo bar ratio and mortar strengthening ratio on bearing capacity of the reinforced columns are compared. We propose the method for calculating the axial bearing capacity of such a reinforced column. The calculation results agree well with the experimental results, and the research results are available for engineering application.
- Published
- 2020
- Full Text
- View/download PDF
13. Experimental Study on Flexural Properties of Side-Pressure Laminated Bamboo Beams
- Author
-
Jing Lei, Bowang Chen, and Ping Yuan
- Subjects
Engineering (General). Civil engineering (General) ,TA1-2040 - Abstract
In this paper, two factors of width-to-height ratio and span-to-height ratio are considered and 10 side-pressure laminated bamboo beams are prepared and tested for flexural capacity to study the flexural performance when they are used as structural members. The failure mode, load-displacement curves, and the change rule of cross-section strain with height are obtained through the test. The results demonstrate that the side-pressure laminated bamboo beams have experienced elastic deformation stage, elastic-plastic deformation stage, and failure stage; the midspan deflection of beams with considerable span-to-height ratio is too large to be applied to the ultimate load, and these specimens are regarded at the ultimate limit state; stiffness or deflection should be considered as the control index in the engineering application of the side-pressure laminated bamboo beams; the bearing capacity increases proportionately with the beam width; the average strain of the section basically conforms to the plane section assumption. The experiment proposes a method for calculating the flexural capacity of the side-pressure laminated bamboo beams with nonlinear deformation, and also, the comparison between the test value and the calculated value shows that they agree well.
- Published
- 2020
- Full Text
- View/download PDF
14. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
- Author
-
Molly Went, Amit Sud, Asta Försti, Britt-Marie Halvarsson, Niels Weinhold, Scott Kimber, Mark van Duin, Gudmar Thorleifsson, Amy Holroyd, David C. Johnson, Ni Li, Giulia Orlando, Philip J. Law, Mina Ali, Bowang Chen, Jonathan S. Mitchell, Daniel F. Gudbjartsson, Rowan Kuiper, Owen W. Stephens, Uta Bertsch, Peter Broderick, Chiara Campo, Obul R Bandapalli, Hermann Einsele, Walter A. Gregory, Urban Gullberg, Jens Hillengass, Per Hoffmann, Graham H. Jackson, Karl-Heinz Jöckel, Ellinor Johnsson, Sigurður Y. Kristinsson, Ulf-Henrik Mellqvist, Hareth Nahi, Douglas Easton, Paul Pharoah, Alison Dunning, Julian Peto, Federico Canzian, Anthony Swerdlow, Rosalind A. Eeles, ZSofia Kote-Jarai, Kenneth Muir, Nora Pashayan, Jolanta Nickel, Markus M. Nöthen, Thorunn Rafnar, Fiona M. Ross, Miguel Inacio da Silva Filho, Hauke Thomsen, Ingemar Turesson, Annette Vangsted, Niels Frost Andersen, Anders Waage, Brian A. Walker, Anna-Karin Wihlborg, Annemiek Broyl, Faith E. Davies, Unnur Thorsteinsdottir, Christian Langer, Markus Hansson, Hartmut Goldschmidt, Martin Kaiser, Pieter Sonneveld, Kari Stefansson, Gareth J. Morgan, Kari Hemminki, Björn Nilsson, Richard S. Houlston, and The PRACTICAL consortium
- Subjects
Science - Abstract
Multiple myeloma is a cancer of the plasma cells, and the complete aetiology of the disease is still unclear. Here the authors perform an additional GWAS analysis followed by a meta-analysis with existing GWAS and replication genotyping and identify 6 novel risk loci and utilise gene expression, epigenetic profiling and in situ Hi-C data to further our understanding of MM susceptibility.
- Published
- 2018
- Full Text
- View/download PDF
15. Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
- Author
-
Molly Went, Amit Sud, Asta Försti, Britt-Marie Halvarsson, Niels Weinhold, Scott Kimber, Mark van Duin, Gudmar Thorleifsson, Amy Holroyd, David C. Johnson, Ni Li, Giulia Orlando, Philip J. Law, Mina Ali, Bowang Chen, Jonathan S. Mitchell, Daniel F. Gudbjartsson, Rowan Kuiper, Owen W. Stephens, Uta Bertsch, Peter Broderick, Chiara Campo, Obul R Bandapalli, Hermann Einsele, Walter A. Gregory, Urban Gullberg, Jens Hillengass, Per Hoffmann, Graham H. Jackson, Karl-Heinz Jöckel, Ellinor Johnsson, Sigurður Y. Kristinsson, Ulf-Henrik Mellqvist, Hareth Nahi, Douglas Easton, Paul Pharoah, Alison Dunning, Julian Peto, Federico Canzian, Anthony Swerdlow, Rosalind A. Eeles, Zsofia Kote-Jarai, Kenneth Muir, Nora Pashayan, The PRACTICAL consortium, Jolanta Nickel, Markus M. Nöthen, Thorunn Rafnar, Fiona M. Ross, Miguel Inacio da Silva Filho, Hauke Thomsen, Ingemar Turesson, Annette Vangsted, Niels Frost Andersen, Anders Waage, Brian A. Walker, Anna-Karin Wihlborg, Annemiek Broyl, Faith E. Davies, Unnur Thorsteinsdottir, Christian Langer, Markus Hansson, Hartmut Goldschmidt, Martin Kaiser, Pieter Sonneveld, Kari Stefansson, Gareth J. Morgan, Kari Hemminki, Björn Nilsson, and Richard S. Houlston
- Subjects
Science - Abstract
The original version of this Article contained an error in the spelling of a member of the PRACTICAL Consortium, Manuela Gago-Dominguez, which was incorrectly given as Manuela Gago Dominguez. This has now been corrected in both the PDF and HTML versions of the Article. Furthermore, in the original HTML version of this Article, the order of authors within the author list was incorrect. The PRACTICAL consortium was incorrectly listed after Richard S. Houlston and should have been listed after Nora Pashayan. This error has been corrected in the HTML version of the Article; the PDF version was correct at the time of publication.
- Published
- 2019
- Full Text
- View/download PDF
16. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
- Author
-
Jonathan S. Mitchell, Ni Li, Niels Weinhold, Asta Försti, Mina Ali, Mark van Duin, Gudmar Thorleifsson, David C. Johnson, Bowang Chen, Britt-Marie Halvarsson, Daniel F. Gudbjartsson, Rowan Kuiper, Owen W. Stephens, Uta Bertsch, Peter Broderick, Chiara Campo, Hermann Einsele, Walter A. Gregory, Urban Gullberg, Marc Henrion, Jens Hillengass, Per Hoffmann, Graham H. Jackson, Ellinor Johnsson, Magnus Jöud, Sigurður Y. Kristinsson, Stig Lenhoff, Oleg Lenive, Ulf-Henrik Mellqvist, Gabriele Migliorini, Hareth Nahi, Sven Nelander, Jolanta Nickel, Markus M. Nöthen, Thorunn Rafnar, Fiona M. Ross, Miguel Inacio da Silva Filho, Bhairavi Swaminathan, Hauke Thomsen, Ingemar Turesson, Annette Vangsted, Ulla Vogel, Anders Waage, Brian A. Walker, Anna-Karin Wihlborg, Annemiek Broyl, Faith E. Davies, Unnur Thorsteinsdottir, Christian Langer, Markus Hansson, Martin Kaiser, Pieter Sonneveld, Kari Stefansson, Gareth J. Morgan, Hartmut Goldschmidt, Kari Hemminki, Björn Nilsson, and Richard S. Houlston
- Subjects
Science - Abstract
Previous genome-wide association studies have identified loci associated with the risk of multiple myeloma. Here, the authors present a meta-analysis of six genome wide association studies of the disease and identify eight new loci; functional studies identify genes as candidates for the basis of these associations.
- Published
- 2016
- Full Text
- View/download PDF
17. Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma
- Author
-
David C. Johnson, Niels Weinhold, Jonathan S. Mitchell, Bowang Chen, Martin Kaiser, Dil B. Begum, Jens Hillengass, Uta Bertsch, Walter A. Gregory, David Cairns, Graham H. Jackson, Asta Försti, Jolanta Nickel, Per Hoffmann, Markus M. Nöethen, Owen W. Stephens, Bart Barlogie, Faith E. Davis, Kari Hemminki, Hartmut Goldschmidt, Richard S. Houlston, and Gareth J. Morgan
- Subjects
Science - Abstract
The prognosis of multiple myeloma patients varies widely. Here, to identify genetic factors associated with differing prognoses, the authors carried out a meta-analysis of four genome-wide association studies and identified a risk variant associated with survival interval.
- Published
- 2016
- Full Text
- View/download PDF
18. Departure from Hardy Weinberg Equilibrium and Genotyping Error
- Author
-
Bowang Chen, John W. Cole, and Caspar Grond-Ginsbach
- Subjects
association studies in genetics ,Hardy Weinberg Equilibrium (HWE) ,heterozygosity ,SNP quality control ,Genetics ,QH426-470 - Abstract
Objective: Departure from Hardy Weinberg Equilibrium (HWE) may occur due to a variety of causes, including purifying selection, inbreeding, population substructure, copy number variation or genotyping error. We searched for specific characteristics of HWE-departure due to genotyping error.Methods: Genotypes of a random set of genetic variants were obtained from the Exome Aggregation Consortium (ExAC) database. Variants with 98%, LoH d-HWE was found in 29 (1.3%) variants, but no GoH d-HWE was detected. The findings of the non-random distribution of HWE-violating SNPs along the chromosome, the association with common deletion polymorphisms and indel-variant type, and the finding of excess heterozygotes in genomic regions that are prone to cross-hybridization were confirmed in a large sample of short variants from the 1,000 Genomes Project.Conclusions: We differentiated between two types of HWE-departure. GoH d-HWE was suggestive for genotyping error. LoH d-HWE, on the contrary, pointed to natural variabilities such as population substructure or common deletion polymorphisms.
- Published
- 2017
- Full Text
- View/download PDF
19. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells
- Author
-
Niels Weinhold, Tobias Meissner, David C Johnson, Anja Seckinger, Jérôme Moreaux, Asta Försti, Bowang Chen, Jolanta Nickel, Daniel Chubb, Andrew C. Rawstron, Chi Doughty, Nasrin B. Dahir, Dil B. Begum, Kwee Young, Brian A. Walker, Per Hoffmann, Marcus M. Nöthen, Faith E. Davies, Bernard Klein, Hartmut Goldschmidt, Gareth J. Morgan, Richard S Houlston, Dirk Hose, and Kari Hemminki
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2015
- Full Text
- View/download PDF
20. Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome.
- Author
-
Andrea Woltmann, Bowang Chen, Jesús Lascorz, Robert Johansson, Jorunn E Eyfjörd, Ute Hamann, Jonas Manjer, Kerstin Enquist-Olsson, Roger Henriksson, Stefan Herms, Per Hoffmann, Kari Hemminki, Per Lenner, and Asta Försti
- Subjects
Medicine ,Science - Abstract
Genome-wide association studies (GWASs) may help to understand the effects of genetic polymorphisms on breast cancer (BC) progression and survival. However, they give only a focused view, which cannot capture the tremendous complexity of this disease. Therefore, we investigated data from a previously conducted GWAS on BC survival for enriched pathways by different enrichment analysis tools using the two main annotation databases Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The goal was to identify the functional categories (GO terms and KEGG pathways) that are consistently overrepresented in a statistically significant way in the list of genes generated from the single nucleotide polymorphism (SNP) data. The SNPs with allelic p-value cut-offs 0.005 and 0.01 were annotated to the genes by excluding or including a 20 kb up-and down-stream sequence of the genes and analyzed by six different tools. We identified eleven consistently enriched categories, the most significant ones relating to cell adhesion and calcium ion binding. Moreover, we investigated the similarity between our GWAS and the enrichment analyses of twelve published gene expression signatures for breast cancer prognosis. Five of them were commonly used and commercially available, five were based on different aspects of metastasis formation and two were developed from meta-analyses of published prognostic signatures. This comparison revealed similarities between our GWAS data and the general and the specific brain metastasis gene signatures as well as the Oncotype DX signature. As metastasis formation is a strong indicator of a patient's prognosis, this result reflects the survival aspect of the conducted GWAS and supports cell adhesion and calcium signaling as important pathways in cancer progression.
- Published
- 2014
- Full Text
- View/download PDF
21. Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies.
- Author
-
Jesús Lascorz, Bowang Chen, Kari Hemminki, and Asta Försti
- Subjects
Medicine ,Science - Abstract
BACKGROUND: A large number of gene expression profiling (GEP) studies on prognosis of colorectal cancer (CRC) has been performed, but no reliable gene signature for prediction of CRC prognosis has been found. Bioinformatic enrichment tools are a powerful approach to identify biological processes in high-throughput data analysis. PRINCIPAL FINDINGS: We have for the first time collected the results from the 23 so far published independent GEP studies on CRC prognosis. In these 23 studies, 1475 unique, mapped genes were identified, from which 124 (8.4%) were reported in at least two studies, with 54 of them showing consisting direction in expression change between the single studies. Using these data, we attempted to overcome the lack of reproducibility observed in the genes reported in individual GEP studies by carrying out a pathway-based enrichment analysis. We used up to ten tools for overrepresentation analysis of Gene Ontology (GO) categories or Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in each of the three gene lists (1475, 124 and 54 genes). This strategy, based on testing multiple tools, allowed us to identify the oxidative phosphorylation chain and the extracellular matrix receptor interaction categories, as well as a general category related to cell proliferation and apoptosis, as the only significantly and consistently overrepresented pathways in the three gene lists, which were reported by several enrichment tools. CONCLUSIONS: Our pathway-based enrichment analysis of 23 independent gene expression profiling studies on prognosis of CRC identified significantly and consistently overrepresented prognostic categories for CRC. These overrepresented categories have been functionally clearly related with cancer progression, and deserve further investigation.
- Published
- 2011
- Full Text
- View/download PDF
22. Prognostic Value of a Multi-mRNA Signature for 1-Year All-Cause Death in Hospitalized Patients With Heart Failure With a Preserved Ejection Fraction.
- Author
-
Yan Gao, Bowang Chen, Yi Han, Jiapeng Lu, Xi Li, Aoxi Tian, Lihua Zhang, Bin Wang, Yun Hong, Jiamin Liu, Yan Li, Wuhan Bilige, Haibo Zhang, Xin Zheng, and Jing Li
- Abstract
BACKGROUND: Heart failure with preserved ejection fraction is a major global public health problem, while effective risk stratification tools are still lacking. We sought to construct a multi-mRNA signature to predict 1-year all-cause death. METHODS: We selected 30 patients with heart failure with preserved ejection fraction who died during 1-year follow-up and 30 who survived in the discovery set. One hundred seventy-one and 120 patients with heart failure with preserved ejection fraction were randomly selected as a test set and a validation set, respectively. We performed mRNA microarrays in all patients. RESULTS: We constructed a 5-mRNA signature for predicting 1-year all-cause death. The scores of the 5-mRNA signature were significantly associated with the 1-year risk of all-cause death in both the test set (hazard ratio, 2.72 [95% CI, 1.98-3.74]; P<0.001) and the validation set (hazard ratio, 3.95 [95% CI, 2.40-6.48]; P<0.001). Compared with a reference model, which included sex, ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) score, history of HF and NT-proBNP (N-terminal pro-B-type natriuretic peptide), the 5-mRNA signature had a better discrimination capability, with an increased area under the curve from 0.696 to 0.813 in the test set and from 0.712 to 0.848 in the validation set. A composite model integrating the 5-mRNA risk score and variables in the reference model demonstrated an excellent discrimination capability, with an area under the curve of 0.861 (95% CI, 0.784-0.939) in the test set and an area under the curve of 0.859 (95% CI, 0.755-0.963) in the validation set. The net reclassification improvement and integrated discrimination improvement indicated that the composite model significantly improved patient classification compared with the reference model in both sets (P<0.001). CONCLUSIONS: The 5-mRNA signature is a promising predictive tool for 1-year all-cause death and shows improved prognostic power over the established risk scores and NT-proBNP in patients with heart failure with preserved ejection fraction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
- Author
-
Eitan Friedman, Antonis C. Antoniou, Georgia Chenevix-Trench, Paul D.P. Pharoah, Andrew Lee, Sue Healey, Daniel Barrowdale, Lesley McGuffog, Karoline B. Kuchenbaecker, Åke Borg, Marie Stenmark Askmalm, Hans Ehrencrona, Anna von Wachenfeldt, Johanna Rantala, Yael Laitman, Uffe Birk Jensen, Mads Thomassen, Inge Sokilde Pedersen, Anders Bojesen, Amanda Ewart Toland, Irene L. Andrulis, Sandrine Tchatchou, Gord Glendon, Anna Marie Mulligan, Gad Rennert, Phuong L. Mai, Mark H. Greene, Catherine M. Phelan, Muy-Kheng M. Tea, Georg Pfeiler, Daphne Geschwantler Kaulich, Christine Rappaport, Christian F. Singer, Andreas Berger, Vijai Joseph, Liying Zhang, Mark E. Robson, Lauren Jacobs, Marina Corines, Kenneth Offit, Csilla I. Szabo, Xianshu Wang, Noralane M. Lindor, Fergus J. Couch, Curtis Olswold, Manuel R. Teixeira, Jocelyne Chiquette, Adalgeir Arason, Grzegorz Sukiennicki, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Jacek Gronwald, Cezary Cybulski, Lidia Feliubadalo, Joan Brunet, Conxi Lazaro, Ignacio Blanco, Orland Diez, Edith Olah, J. Margriet Collée, Helena C. van Doorn, Margreet G.E.M. Ausems, Nicoline Hoogerbrugge, Maaike P.G. Vreeswijk, Annemarie H. van der Hout, Hanne E.J. Meijers-Heijboer, Theo A.M. van Os, Kristiina Aittomäki, Heli Nevanlinna, Pedro Perez Segura, Miguel de la Hoya, Larry J. Copeland, Gustavo C. Rodriguez, Michael L. Friedlander, Marion Piedmonte, Muriel Belotti, Sylvie Mazoyer, Pascal Pujol, Olivier Caron, Olga M. Sinilnikova, Nadia Boutry-Kryza, Lisa Golmard, Laurence Venat-Bouvet, Laure Barjhoux, Isabelle Coupier, Francesca Damiola, Dominique Stoppa-Lyonnet, Claude Houdayer, Capucine Delnatte, Bruno Buecher, Brigitte Bressac-de Paillerets, Shan Wang-Gohrke, Barbara Wappenschmidt, Raymonda Varon-Mateeva, Norbert Arnold, Nina Ditsch, Kerstin Rhiem, Karin Kast, Hansjoerg Plendl, Doris Steinemann, Dieter Niederacher, Christoph Engel, Christian Sutter, Andrea Gehrig, Alfons Meindl, Tom Van Maerken, Kathleen Claes, Andrew K. Godwin, Trevor Cole, Steve Ellis, Shirley V. Hodgson, Rosemarie Davidson, Radka Platte, Patrick J. Morrison, Mary E. Porteous, Mark T. Rogers, M. John Kennedy, Lucy E. Side, Louise Izatt, Lisa Walker, Julian Barwell, Julian Adlard, Marc Tischkowitz, Jackie Cook, Angela Brady, Diana Eccles, Debra Frost, D. Gareth R. Evans, Claire Foo, Carole Brewer, Alan Donaldson, Judy E. Garber, Florentia Fostira, Athanassios Vratimos, Paolo Radice, Maria Grazia Tibiletti, Aline Martayan, Laura Papi, Giuseppe Giannini, Alessandra Viel, Stefano Fortuzzi, Frederique Mariette, Filomena Ficarazzi, Monica Barile, Giulietta Scuvera, Daniela Zaffaroni, Bernard Peissel, Siranoush Manoukian, Jeffrey N. Weitzel, Kathleen R. Blazer, Edye E. Conway, Javier Benitez, Cristina Martínez-Bouzas, Ana Osorio, Lars Jønson, Bent Ejlertsen, Anne-Marie Gerdes, Thomas V.O. Hansen, Susan L. Neuhausen, Yuan Chun Ding, Elizabeth J. van Rensburg, Cecilia M. Dorfling, Ramunas Janavicius, Saundra S. Buys, David E. Goldgar, Melissa C. Southey, Alex Miron, Wendy K. Chung, Jenny Lester, Sandra Orsulic, Beth Y. Karlan, Banu K. Arun, Timothy R. Rebbeck, Susan M. Domchek, Katherine L. Nathanson, Robert L. Nussbaum, Olufunmilayo I. Olopade, Encarna B. Gómez Garcia, Anna Jakubowska, Jan Lubinski, Laura Matricardi, Marco Montagna, Ana-Teresa Maia, Felicity Lose, Logan C. Walker, Amanda B. Spurdle, Frederieke H. van der Baan, Marjanka K. Schmidt, Matti A. Rookus, Bowang Chen, Stefan Wilkening, Ute Hamann, Douglas F. Easton, Rosalind A. Eeles, Penny Soucy, Jacques Simard, Rita K. Schmutzler, Anja Rudolph, Kirsten B. Moysich, Jenny Chang-Claude, and Paolo Peterlongo
- Abstract
Supplementary Table 2. Results of the statistical analyses in BRCA mutation carriers.
- Published
- 2023
- Full Text
- View/download PDF
24. Supplementary Table 1 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
- Author
-
Eitan Friedman, Antonis C. Antoniou, Georgia Chenevix-Trench, Paul D.P. Pharoah, Andrew Lee, Sue Healey, Daniel Barrowdale, Lesley McGuffog, Karoline B. Kuchenbaecker, Åke Borg, Marie Stenmark Askmalm, Hans Ehrencrona, Anna von Wachenfeldt, Johanna Rantala, Yael Laitman, Uffe Birk Jensen, Mads Thomassen, Inge Sokilde Pedersen, Anders Bojesen, Amanda Ewart Toland, Irene L. Andrulis, Sandrine Tchatchou, Gord Glendon, Anna Marie Mulligan, Gad Rennert, Phuong L. Mai, Mark H. Greene, Catherine M. Phelan, Muy-Kheng M. Tea, Georg Pfeiler, Daphne Geschwantler Kaulich, Christine Rappaport, Christian F. Singer, Andreas Berger, Vijai Joseph, Liying Zhang, Mark E. Robson, Lauren Jacobs, Marina Corines, Kenneth Offit, Csilla I. Szabo, Xianshu Wang, Noralane M. Lindor, Fergus J. Couch, Curtis Olswold, Manuel R. Teixeira, Jocelyne Chiquette, Adalgeir Arason, Grzegorz Sukiennicki, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Jacek Gronwald, Cezary Cybulski, Lidia Feliubadalo, Joan Brunet, Conxi Lazaro, Ignacio Blanco, Orland Diez, Edith Olah, J. Margriet Collée, Helena C. van Doorn, Margreet G.E.M. Ausems, Nicoline Hoogerbrugge, Maaike P.G. Vreeswijk, Annemarie H. van der Hout, Hanne E.J. Meijers-Heijboer, Theo A.M. van Os, Kristiina Aittomäki, Heli Nevanlinna, Pedro Perez Segura, Miguel de la Hoya, Larry J. Copeland, Gustavo C. Rodriguez, Michael L. Friedlander, Marion Piedmonte, Muriel Belotti, Sylvie Mazoyer, Pascal Pujol, Olivier Caron, Olga M. Sinilnikova, Nadia Boutry-Kryza, Lisa Golmard, Laurence Venat-Bouvet, Laure Barjhoux, Isabelle Coupier, Francesca Damiola, Dominique Stoppa-Lyonnet, Claude Houdayer, Capucine Delnatte, Bruno Buecher, Brigitte Bressac-de Paillerets, Shan Wang-Gohrke, Barbara Wappenschmidt, Raymonda Varon-Mateeva, Norbert Arnold, Nina Ditsch, Kerstin Rhiem, Karin Kast, Hansjoerg Plendl, Doris Steinemann, Dieter Niederacher, Christoph Engel, Christian Sutter, Andrea Gehrig, Alfons Meindl, Tom Van Maerken, Kathleen Claes, Andrew K. Godwin, Trevor Cole, Steve Ellis, Shirley V. Hodgson, Rosemarie Davidson, Radka Platte, Patrick J. Morrison, Mary E. Porteous, Mark T. Rogers, M. John Kennedy, Lucy E. Side, Louise Izatt, Lisa Walker, Julian Barwell, Julian Adlard, Marc Tischkowitz, Jackie Cook, Angela Brady, Diana Eccles, Debra Frost, D. Gareth R. Evans, Claire Foo, Carole Brewer, Alan Donaldson, Judy E. Garber, Florentia Fostira, Athanassios Vratimos, Paolo Radice, Maria Grazia Tibiletti, Aline Martayan, Laura Papi, Giuseppe Giannini, Alessandra Viel, Stefano Fortuzzi, Frederique Mariette, Filomena Ficarazzi, Monica Barile, Giulietta Scuvera, Daniela Zaffaroni, Bernard Peissel, Siranoush Manoukian, Jeffrey N. Weitzel, Kathleen R. Blazer, Edye E. Conway, Javier Benitez, Cristina Martínez-Bouzas, Ana Osorio, Lars Jønson, Bent Ejlertsen, Anne-Marie Gerdes, Thomas V.O. Hansen, Susan L. Neuhausen, Yuan Chun Ding, Elizabeth J. van Rensburg, Cecilia M. Dorfling, Ramunas Janavicius, Saundra S. Buys, David E. Goldgar, Melissa C. Southey, Alex Miron, Wendy K. Chung, Jenny Lester, Sandra Orsulic, Beth Y. Karlan, Banu K. Arun, Timothy R. Rebbeck, Susan M. Domchek, Katherine L. Nathanson, Robert L. Nussbaum, Olufunmilayo I. Olopade, Encarna B. Gómez Garcia, Anna Jakubowska, Jan Lubinski, Laura Matricardi, Marco Montagna, Ana-Teresa Maia, Felicity Lose, Logan C. Walker, Amanda B. Spurdle, Frederieke H. van der Baan, Marjanka K. Schmidt, Matti A. Rookus, Bowang Chen, Stefan Wilkening, Ute Hamann, Douglas F. Easton, Rosalind A. Eeles, Penny Soucy, Jacques Simard, Rita K. Schmutzler, Anja Rudolph, Kirsten B. Moysich, Jenny Chang-Claude, and Paolo Peterlongo
- Abstract
Supplementary Table 1. The 3,248 SNPs included in the study
- Published
- 2023
- Full Text
- View/download PDF
25. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
- Author
-
Eitan Friedman, Antonis C. Antoniou, Georgia Chenevix-Trench, Paul D.P. Pharoah, Andrew Lee, Sue Healey, Daniel Barrowdale, Lesley McGuffog, Karoline B. Kuchenbaecker, Åke Borg, Marie Stenmark Askmalm, Hans Ehrencrona, Anna von Wachenfeldt, Johanna Rantala, Yael Laitman, Uffe Birk Jensen, Mads Thomassen, Inge Sokilde Pedersen, Anders Bojesen, Amanda Ewart Toland, Irene L. Andrulis, Sandrine Tchatchou, Gord Glendon, Anna Marie Mulligan, Gad Rennert, Phuong L. Mai, Mark H. Greene, Catherine M. Phelan, Muy-Kheng M. Tea, Georg Pfeiler, Daphne Geschwantler Kaulich, Christine Rappaport, Christian F. Singer, Andreas Berger, Vijai Joseph, Liying Zhang, Mark E. Robson, Lauren Jacobs, Marina Corines, Kenneth Offit, Csilla I. Szabo, Xianshu Wang, Noralane M. Lindor, Fergus J. Couch, Curtis Olswold, Manuel R. Teixeira, Jocelyne Chiquette, Adalgeir Arason, Grzegorz Sukiennicki, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Jacek Gronwald, Cezary Cybulski, Lidia Feliubadalo, Joan Brunet, Conxi Lazaro, Ignacio Blanco, Orland Diez, Edith Olah, J. Margriet Collée, Helena C. van Doorn, Margreet G.E.M. Ausems, Nicoline Hoogerbrugge, Maaike P.G. Vreeswijk, Annemarie H. van der Hout, Hanne E.J. Meijers-Heijboer, Theo A.M. van Os, Kristiina Aittomäki, Heli Nevanlinna, Pedro Perez Segura, Miguel de la Hoya, Larry J. Copeland, Gustavo C. Rodriguez, Michael L. Friedlander, Marion Piedmonte, Muriel Belotti, Sylvie Mazoyer, Pascal Pujol, Olivier Caron, Olga M. Sinilnikova, Nadia Boutry-Kryza, Lisa Golmard, Laurence Venat-Bouvet, Laure Barjhoux, Isabelle Coupier, Francesca Damiola, Dominique Stoppa-Lyonnet, Claude Houdayer, Capucine Delnatte, Bruno Buecher, Brigitte Bressac-de Paillerets, Shan Wang-Gohrke, Barbara Wappenschmidt, Raymonda Varon-Mateeva, Norbert Arnold, Nina Ditsch, Kerstin Rhiem, Karin Kast, Hansjoerg Plendl, Doris Steinemann, Dieter Niederacher, Christoph Engel, Christian Sutter, Andrea Gehrig, Alfons Meindl, Tom Van Maerken, Kathleen Claes, Andrew K. Godwin, Trevor Cole, Steve Ellis, Shirley V. Hodgson, Rosemarie Davidson, Radka Platte, Patrick J. Morrison, Mary E. Porteous, Mark T. Rogers, M. John Kennedy, Lucy E. Side, Louise Izatt, Lisa Walker, Julian Barwell, Julian Adlard, Marc Tischkowitz, Jackie Cook, Angela Brady, Diana Eccles, Debra Frost, D. Gareth R. Evans, Claire Foo, Carole Brewer, Alan Donaldson, Judy E. Garber, Florentia Fostira, Athanassios Vratimos, Paolo Radice, Maria Grazia Tibiletti, Aline Martayan, Laura Papi, Giuseppe Giannini, Alessandra Viel, Stefano Fortuzzi, Frederique Mariette, Filomena Ficarazzi, Monica Barile, Giulietta Scuvera, Daniela Zaffaroni, Bernard Peissel, Siranoush Manoukian, Jeffrey N. Weitzel, Kathleen R. Blazer, Edye E. Conway, Javier Benitez, Cristina Martínez-Bouzas, Ana Osorio, Lars Jønson, Bent Ejlertsen, Anne-Marie Gerdes, Thomas V.O. Hansen, Susan L. Neuhausen, Yuan Chun Ding, Elizabeth J. van Rensburg, Cecilia M. Dorfling, Ramunas Janavicius, Saundra S. Buys, David E. Goldgar, Melissa C. Southey, Alex Miron, Wendy K. Chung, Jenny Lester, Sandra Orsulic, Beth Y. Karlan, Banu K. Arun, Timothy R. Rebbeck, Susan M. Domchek, Katherine L. Nathanson, Robert L. Nussbaum, Olufunmilayo I. Olopade, Encarna B. Gómez Garcia, Anna Jakubowska, Jan Lubinski, Laura Matricardi, Marco Montagna, Ana-Teresa Maia, Felicity Lose, Logan C. Walker, Amanda B. Spurdle, Frederieke H. van der Baan, Marjanka K. Schmidt, Matti A. Rookus, Bowang Chen, Stefan Wilkening, Ute Hamann, Douglas F. Easton, Rosalind A. Eeles, Penny Soucy, Jacques Simard, Rita K. Schmutzler, Anja Rudolph, Kirsten B. Moysich, Jenny Chang-Claude, and Paolo Peterlongo
- Abstract
Supplementary Table 3. Results of the statistical analyses of SNPs from project 12 in BRCA-mutation carriers affected or non-affected with breast cancer and according to their estrogen receptor status.
- Published
- 2023
- Full Text
- View/download PDF
26. Data from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
- Author
-
Eitan Friedman, Antonis C. Antoniou, Georgia Chenevix-Trench, Paul D.P. Pharoah, Andrew Lee, Sue Healey, Daniel Barrowdale, Lesley McGuffog, Karoline B. Kuchenbaecker, Åke Borg, Marie Stenmark Askmalm, Hans Ehrencrona, Anna von Wachenfeldt, Johanna Rantala, Yael Laitman, Uffe Birk Jensen, Mads Thomassen, Inge Sokilde Pedersen, Anders Bojesen, Amanda Ewart Toland, Irene L. Andrulis, Sandrine Tchatchou, Gord Glendon, Anna Marie Mulligan, Gad Rennert, Phuong L. Mai, Mark H. Greene, Catherine M. Phelan, Muy-Kheng M. Tea, Georg Pfeiler, Daphne Geschwantler Kaulich, Christine Rappaport, Christian F. Singer, Andreas Berger, Vijai Joseph, Liying Zhang, Mark E. Robson, Lauren Jacobs, Marina Corines, Kenneth Offit, Csilla I. Szabo, Xianshu Wang, Noralane M. Lindor, Fergus J. Couch, Curtis Olswold, Manuel R. Teixeira, Jocelyne Chiquette, Adalgeir Arason, Grzegorz Sukiennicki, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Jacek Gronwald, Cezary Cybulski, Lidia Feliubadalo, Joan Brunet, Conxi Lazaro, Ignacio Blanco, Orland Diez, Edith Olah, J. Margriet Collée, Helena C. van Doorn, Margreet G.E.M. Ausems, Nicoline Hoogerbrugge, Maaike P.G. Vreeswijk, Annemarie H. van der Hout, Hanne E.J. Meijers-Heijboer, Theo A.M. van Os, Kristiina Aittomäki, Heli Nevanlinna, Pedro Perez Segura, Miguel de la Hoya, Larry J. Copeland, Gustavo C. Rodriguez, Michael L. Friedlander, Marion Piedmonte, Muriel Belotti, Sylvie Mazoyer, Pascal Pujol, Olivier Caron, Olga M. Sinilnikova, Nadia Boutry-Kryza, Lisa Golmard, Laurence Venat-Bouvet, Laure Barjhoux, Isabelle Coupier, Francesca Damiola, Dominique Stoppa-Lyonnet, Claude Houdayer, Capucine Delnatte, Bruno Buecher, Brigitte Bressac-de Paillerets, Shan Wang-Gohrke, Barbara Wappenschmidt, Raymonda Varon-Mateeva, Norbert Arnold, Nina Ditsch, Kerstin Rhiem, Karin Kast, Hansjoerg Plendl, Doris Steinemann, Dieter Niederacher, Christoph Engel, Christian Sutter, Andrea Gehrig, Alfons Meindl, Tom Van Maerken, Kathleen Claes, Andrew K. Godwin, Trevor Cole, Steve Ellis, Shirley V. Hodgson, Rosemarie Davidson, Radka Platte, Patrick J. Morrison, Mary E. Porteous, Mark T. Rogers, M. John Kennedy, Lucy E. Side, Louise Izatt, Lisa Walker, Julian Barwell, Julian Adlard, Marc Tischkowitz, Jackie Cook, Angela Brady, Diana Eccles, Debra Frost, D. Gareth R. Evans, Claire Foo, Carole Brewer, Alan Donaldson, Judy E. Garber, Florentia Fostira, Athanassios Vratimos, Paolo Radice, Maria Grazia Tibiletti, Aline Martayan, Laura Papi, Giuseppe Giannini, Alessandra Viel, Stefano Fortuzzi, Frederique Mariette, Filomena Ficarazzi, Monica Barile, Giulietta Scuvera, Daniela Zaffaroni, Bernard Peissel, Siranoush Manoukian, Jeffrey N. Weitzel, Kathleen R. Blazer, Edye E. Conway, Javier Benitez, Cristina Martínez-Bouzas, Ana Osorio, Lars Jønson, Bent Ejlertsen, Anne-Marie Gerdes, Thomas V.O. Hansen, Susan L. Neuhausen, Yuan Chun Ding, Elizabeth J. van Rensburg, Cecilia M. Dorfling, Ramunas Janavicius, Saundra S. Buys, David E. Goldgar, Melissa C. Southey, Alex Miron, Wendy K. Chung, Jenny Lester, Sandra Orsulic, Beth Y. Karlan, Banu K. Arun, Timothy R. Rebbeck, Susan M. Domchek, Katherine L. Nathanson, Robert L. Nussbaum, Olufunmilayo I. Olopade, Encarna B. Gómez Garcia, Anna Jakubowska, Jan Lubinski, Laura Matricardi, Marco Montagna, Ana-Teresa Maia, Felicity Lose, Logan C. Walker, Amanda B. Spurdle, Frederieke H. van der Baan, Marjanka K. Schmidt, Matti A. Rookus, Bowang Chen, Stefan Wilkening, Ute Hamann, Douglas F. Easton, Rosalind A. Eeles, Penny Soucy, Jacques Simard, Rita K. Schmutzler, Anja Rudolph, Kirsten B. Moysich, Jenny Chang-Claude, and Paolo Peterlongo
- Abstract
Background:BRCA1 and BRCA2 mutation carriers are at substantially increased risk for developing breast and ovarian cancer. The incomplete penetrance coupled with the variable age at diagnosis in carriers of the same mutation suggests the existence of genetic and nongenetic modifying factors. In this study, we evaluated the putative role of variants in many candidate modifier genes.Methods: Genotyping data from 15,252 BRCA1 and 8,211 BRCA2 mutation carriers, for known variants (n = 3,248) located within or around 445 candidate genes, were available through the iCOGS custom-designed array. Breast and ovarian cancer association analysis was performed within a retrospective cohort approach.Results: The observed P values of association ranged between 0.005 and 1.000. None of the variants was significantly associated with breast or ovarian cancer risk in either BRCA1 or BRCA2 mutation carriers, after multiple testing adjustments.Conclusion: There is little evidence that any of the evaluated candidate variants act as modifiers of breast and/or ovarian cancer risk in BRCA1 or BRCA2 mutation carriers.Impact: Genome-wide association studies have been more successful at identifying genetic modifiers of BRCA1/2 penetrance than candidate gene studies. Cancer Epidemiol Biomarkers Prev; 24(1); 308–16. ©2014 AACR.
- Published
- 2023
- Full Text
- View/download PDF
27. Supplementary Tables S1-S3 from A Comprehensive Meta-analysis of Case–Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma
- Author
-
Stefano Landi, Asta Försti, Federica Gemignani, Kari Hemminki, Alfonso Cristaudo, Aleksandra Köhler, Bowang Chen, Franco Bambi, Monica Cipollini, Ombretta Melaiu, Cristina Romei, Rossella Elisei, and Gisella Figlioli
- Abstract
Table S1. Comparison between results from literature and results from the present GWAS for all the SNPs extracted from literature. Table S2. Data published in literature where only one genetic model (either dominant or recessive) was reported in the manuscript. No allelic OR or additive model could be evaluated according to the data reported in the manuscript. Table S3. Meta-analyses of the literature data for the SNPs evaluated in two or more than one study.
- Published
- 2023
- Full Text
- View/download PDF
28. Data from A Comprehensive Meta-analysis of Case–Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma
- Author
-
Stefano Landi, Asta Försti, Federica Gemignani, Kari Hemminki, Alfonso Cristaudo, Aleksandra Köhler, Bowang Chen, Franco Bambi, Monica Cipollini, Ombretta Melaiu, Cristina Romei, Rossella Elisei, and Gisella Figlioli
- Abstract
Background: Linkage analyses and association studies suggested that inherited genetic variations play a role in the development of differentiated thyroid carcinoma (DTC).Methods: We combined the results from a genome-wide association study (GWAS) performed by our group and from published studies on DTC. With a first approach, we evaluated whether a SNP published as associated with the risk of DTC could replicate in our GWAS (using FDR as adjustment for multiple comparisons). With the second approach, meta-analyses were performed between literature and GWAS when both sources suggested an association, increasing the statistical power of the analysis.Results: rs1799814 (CYP1A1), rs1121980 (FTO), and 3 SNPs within 9q22 (rs965513, rs7048394, and rs894673) replicated the associations described in the literature. In addition, the meta-analyses between literature and GWAS revealed 10 more SNPs within 9q22, six within FTO, two within SOD1, and single variations within HUS1, WDR3, UGT2B7, ALOX12, TICAM1, ATG16L1, HDAC4, PIK3CA, SULF1, IL11RA, VEGFA, and 1p31.3, 2q35, 8p12, and 14q13.Conclusion: This analysis confirmed several published risk loci that could be involved in DTC predisposition.Impact: These findings provide evidence for the role of germline variants in DTC etiology and are consistent with a polygenic model of the disease. Cancer Epidemiol Biomarkers Prev; 25(4); 700–13. ©2016 AACR.
- Published
- 2023
- Full Text
- View/download PDF
29. A case report: extracorporeal membrane oxygenation for multitrauma patient with pneumorrhagia
- Author
-
Meng Qiang, Changwei Ji, Zhen Ma, Bowang Chen, Hao Zhang, Jun Li, Lin Cong, Feng Qu, and Shuhong Gao
- Subjects
General Medicine - Abstract
Background Extracorporeal membrane oxygenation (ECMO) can be used as salvage therapy for multitrauma patients with acute respiratory distress syndrome (ARDS) when conventional treatment fails to maintain oxygenation. However, controversy exists between ECMO application and the risk of bleeding due to systemic anticoagulation during the treatment. Non-heparin introduction seems to be a possible solution for this dilemma, owing to technical improvements in the device and management methods of ECMO. Case presentation A 58-year-old woman suffered from blunt thoracic, pelvic, and right lower limb fractures due to a falling accident, which resulted in acute respiratory distress syndrome (ARDS). Although the patient received intubation and mechanical ventilation (MV), respiratory failure was not alleviated. Venous-venous (V-V) ECMO was used as a salvage therapy. With the support of V-V ECMO, we safely cleared blood clots in the bronchus and avoided secondary lung injury caused by pressure trauma and oxygen poisoning of the MV. We introduced heparin-free ECMO management as a solution to reduce the risk of bleeding associated with pulmonary contusion and other organ injuries. To prevent thrombosis, we set the blood rate of ECMO to 4.0 L/min, which is much higher than the usual parameter. During ECMO, coagulation factors, such as prothrombin time, activated partial thromboplastin time, and D-dimer, were examined. ECMO was maintained for 5 days without any complications; MV was stopped on the 13th day, extubated on the 24th day, and discharged from ICU on the 28th day. Conclusion ECMO with non-heparin could be an optimal treatment for multitrauma patients with ARDS when traditional treatment cannot sustain oxygenation. High blood flow rate could prevent thrombosis through ongoing ECMO therapy without systemic anticoagulation. In addition, monitoring D-dimer value change (Δ D-dimer) may be better than D-dimer value in predicting clot formation in the membrane oxygenator.
- Published
- 2023
- Full Text
- View/download PDF
30. Experimental Study and Theoretical Analysis of Side-Pressure Laminated Bamboo Lumber Columns under Axial Compression
- Author
-
Shuai Liu, Danping Gao, Yazi Xie, and Bowang Chen
- Subjects
Renewable Energy, Sustainability and the Environment ,side-pressure laminated bamboo lumber ,axial compression ,experimental study ,pressure bar stability analysis ,displacement calculation ,Geography, Planning and Development ,Building and Construction ,Management, Monitoring, Policy and Law - Abstract
Side-pressure laminated bamboo lumber is made by gluing and pressing bamboo sheets together and can be used as a structural building material. The experiment and theoretical analysis are carried out for the side-pressure laminated bamboo lumber columns under axial compression in order to understand its performance under axial compression. In the experiment, the curve of load and lateral displacement in the middle of columns with different slenderness ratios is obtained under axial compression by considering the slenderness ratio (range: 23.1–92.4) of the specimen as a variable. Results show that the specimen undergoes an elastic stage, elastic-plastic stage, and failure stage when subjected to stress. The failure is characterized by a prominent ductility during this period. With an increase in the slenderness ratio, the elastic stage for the specimen is shortened, while the elastic-plastic stage is extended. Based on the geometric non-linear analysis, the pressure bar stability is analyzed for the specimen through the large deflection theory. A stable differential equation of the side-pressure laminated bamboo lumber column is established under axial compression. Based on the differential equation, the relationship between the bearing capacity of the axial center of the side-pressure laminated bamboo lumber column under axial compression and the lateral displacement in the middle of column can be derived as the reference for the application of side-pressure laminated bamboo lumber.
- Published
- 2022
- Full Text
- View/download PDF
31. Experimental Study on Axial Compression Behavior of Masonry Columns’ Strengthening with Bamboo Scrimber Bar Mesh Mortar Layer
- Author
-
Min Lei, Hongyao Liu, and Bowang Chen
- Subjects
Bamboo ,Materials science ,Article Subject ,business.industry ,Bar (music) ,0211 other engineering and technologies ,020101 civil engineering ,02 engineering and technology ,Structural engineering ,Masonry ,Engineering (General). Civil engineering (General) ,0201 civil engineering ,Column (typography) ,021105 building & construction ,Bearing capacity ,TA1-2040 ,Mortar ,business ,Layer (electronics) ,Failure mode and effects analysis ,Civil and Structural Engineering - Abstract
We propose a new method to strengthen structural masonry. To study on the axial compression behavior of masonry columns’ strengthening with a bamboo scrimber bar mesh mortar layer, axial compression tests of twelve masonry columns have been completed: nine strengthened columns and three unstrengthened columns. The failure process, bearing capacity, and failure mode are carried out. The strengthening method of bamboo scrimber bar mesh mortar layer permits the upgrade of the columns’ bearing capacity. The effects of bamboo bar ratio and mortar strengthening ratio on bearing capacity of the reinforced columns are compared. We propose the method for calculating the axial bearing capacity of such a reinforced column. The calculation results agree well with the experimental results, and the research results are available for engineering application.
- Published
- 2020
- Full Text
- View/download PDF
32. Experimental investigation on Steel-Bamboo Composite shear connections
- Author
-
Shuai Liu, Danping Gao, and Bowang Chen
- Subjects
Mechanics of Materials ,Architecture ,Building and Construction ,Safety, Risk, Reliability and Quality ,Civil and Structural Engineering - Published
- 2022
- Full Text
- View/download PDF
33. Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–2018
- Author
-
Xiaofang Yan, Chaoqun Wu, Jiapeng Lu, Yuan Lu, Bowang Chen, Zhihong Zhu, Erica S. Spatz, Jiamin Liu, Harlan M. Krumholz, Xin Zheng, Guohai Zhou, Lin Mu, and Khurram Nasir
- Subjects
Adult ,Male ,China ,demography ,obesity ,prevalence ,body mass index ,socioeconomic factors ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Environmental health ,Humans ,Medicine ,030212 general & internal medicine ,Aged ,business.industry ,Chinese adults ,Original Articles ,waist circumference ,medicine.disease ,Obesity ,Cross-Sectional Studies ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Female ,Cardiology and Cardiovascular Medicine ,business ,Body mass index - Abstract
Supplemental Digital Content is available in the text., Background: China has seen a burgeoning epidemic of obesity in recent decades, but few studies reported nationally on obesity across socio-demographic subgroups. We sought to assess the prevalence and socio-demographic associations of obesity nationwide. Methods: We assessed the prevalence of overall obesity (body mass index ≥28 kg/m2) and abdominal obesity (waist circumference ≥85/90 cm for women/men) among 2.7 million community-dwelling adults aged 35 to 75 years in the China PEACE Million Persons Project from 2014 to 2018 and quantified the socio-demographic associations of obesity using multivariable mixed models. Results: Age-standardized rates of overall and abdominal obesity were 14.4% (95% CI, 14.3%–14.4%) and 32.7% (32.6%–32.8%) in women and 16.0% (15.9%–16.1%) and 36.6% (36.5%–36.8%) in men. Obesity varied considerably across socio-demographic subgroups. Older women were at higher risk for obesity (eg, adjusted relative risk [95% CI] of women aged 65–75 versus 35–44 years: 1.29 [1.27–1.31] for overall obesity, 1.76 [1.74–1.77] for abdominal obesity) while older men were not. Higher education was associated with lower risk in women (eg, adjusted relative risk [95% CI] of those with college or university education versus below primary school: 0.47 [0.46–0.48] for overall obesity, 0.61 [0.60–0.62] for abdominal obesity) but higher risk in men (1.07 [1.05–1.10], 1.17 [1.16–1.19]). Conclusions: In China, over 1 in 7 individuals meet criteria for overall obesity, and 1 in 3 for abdominal obesity. Wide variation exists across socio-demographic subgroups. The associations of age and education with obesity are significant and differ by sex. Understanding obesity in contemporary China has broad domestic policy implications and provides a valuable international reference.
- Published
- 2021
- Full Text
- View/download PDF
34. Stroke
- Author
-
Christina Jern, Martin Stenman, Tobias Brandt, Sandra Freitag-Wolf, Braxton D. Mitchell, Manja Kloss, Didier Leys, Jonathan Rosand, Stefan T. Engelter, Michael Krawczak, Steven J. Kittner, Vincent Thijs, Giacomo Giacalone, Daniel Woo, J.J. Martin, Jordi Jimenez-Conde, Philip Ginsbach, Emmanuel Touzé, Armin J. Grau, Elisabetta Del Zotto, Tiina M. Metso, Philipp Erhart, Eyad Hayani, Dorothea Pfeiffer, Christoph Lichy, I. Werner, Valeria Caso, Bowang Chen, Antti J. Metso, Caspar Grond-Ginsbach, Arne Lindgren, Shérine Abboud, Anna Bersano, Natalia S. Rost, Kristina Schlicht, Jane Maguire, John W. Cole, Robin Lemmens, Alessandro Pezzini, Jin-Moo Lee, Philippe Lyrer, Steve Bevan, Christopher Traenka, Stéphanie Debette, Turgut Tatlisumak, Bordeaux population health (BPH), and Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
DNA copy number variations ,Neurology ,Gene Dosage ,Logistic regression ,Severity of Illness Index ,Brain Ischemia ,0302 clinical medicine ,Modified Rankin Scale ,Gene Duplication ,Chromosomes, Human ,genetics ,Stroke ,RISK ,0303 health sciences ,Middle Aged ,stroke ,VINTAGE ,Medical genetics ,Cardiology and Cardiovascular Medicine ,Life Sciences & Biomedicine ,Adult ,medicine.medical_specialty ,Genotype ,Clinical Neurology ,Subgroup analysis ,COPY-NUMBER VARIATION ,Polymorphism, Single Nucleotide ,Article ,03 medical and health sciences ,Genetic imbalance ,Internal medicine ,OHNOLOGS ,medicine ,Humans ,Aged ,030304 developmental biology ,Advanced and Specialized Nursing ,Science & Technology ,Neurology & Neurosurgery ,business.industry ,GENOME-WIDE ,Recovery of Function ,Odds ratio ,medicine.disease ,Peripheral Vascular Disease ,Cardiovascular System & Cardiology ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Neurosciences & Neurology ,prognosis ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
Background and Purpose— We sought to explore the effect of genetic imbalance on functional outcome after ischemic stroke (IS). Methods— Copy number variation was identified in high-density single-nucleotide polymorphism microarray data of IS patients from the CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) and SiGN (Stroke Genetics Network)/GISCOME (Genetics of Ischaemic Stroke Functional Outcome) networks. Genetic imbalance, defined as total number of protein-coding genes affected by copy number variations in an individual, was compared between patients with favorable (modified Rankin Scale score of 0–2) and unfavorable (modified Rankin Scale score of ≥3) outcome after 3 months. Subgroup analyses were confined to patients with imbalance affecting ohnologs—a class of dose-sensitive genes, or to those with imbalance not affecting ohnologs. The association of imbalance with outcome was analyzed by logistic regression analysis, adjusted for age, sex, stroke subtype, stroke severity, and ancestry. Results— The study sample comprised 816 CADISP patients (age 44.2±10.3 years) and 2498 SiGN/GISCOME patients (age 67.7±14.2 years). Outcome was unfavorable in 122 CADISP and 889 SiGN/GISCOME patients. Multivariate logistic regression analysis revealed that increased genetic imbalance was associated with less favorable outcome in both samples (CADISP: P =0.0007; odds ratio=0.89; 95% CI, 0.82–0.95 and SiGN/GISCOME: P =0.0036; odds ratio=0.94; 95% CI, 0.91–0.98). The association was independent of age, sex, stroke severity on admission, stroke subtype, and ancestry. On subgroup analysis, imbalance affecting ohnologs was associated with outcome (CADISP: odds ratio=0.88; 95% CI, 0.80–0.95 and SiGN/GISCOME: odds ratio=0.93; 95% CI, 0.89–0.98) whereas imbalance without ohnologs lacked such an association. Conclusions— Increased genetic imbalance was associated with poorer functional outcome after IS in both study populations. Subgroup analysis revealed that this association was driven by presence of ohnologs in the respective copy number variations, suggesting a causal role of the deleterious effects of genetic imbalance.
- Published
- 2019
- Full Text
- View/download PDF
35. Additional file 2 of Genome-wide analysis of DNA methylation and risk of cardiovascular disease in a Chinese population
- Author
-
Gao, Yan, Huifang Pang, Bowang Chen, ChaoQun Wu, Yanping Wang, Libo Hou, Siming Wang, Dianjianyi Sun, and Zheng, Xin
- Subjects
surgical procedures, operative ,bacterial infections and mycoses ,neoplasms ,digestive system ,digestive system diseases - Abstract
Additional file 2: Appendix 1–3. Appendix 1. Significantly functions categories in Gene Ontology (GO) enrichment analysis in discovery set. Appendix 2. Significant Differentially Methylated Regions (DMRs) with annotated genes by hump-hunting method in the discovery group. Appendix 3. Significant Differentially Methylated Regions (DMRs) with annotated genes by Probe Lasso method in the discovery group.
- Published
- 2021
- Full Text
- View/download PDF
36. Genome-wide analysis of DNA methylation and risk of cardiovascular disease in a Chinese population
- Author
-
Si-Ming Wang, Xin Zheng, Yan Gao, Chaoqun Wu, Dianjianyi Sun, Hui-Fang Pang, Yan-Ping Wang, Bowang Chen, and Libo Hou
- Subjects
Oncology ,False discovery rate ,Adult ,Epigenomics ,Male ,medicine.medical_specialty ,China ,Disease ,030204 cardiovascular system & hematology ,Risk Assessment ,03 medical and health sciences ,Epigenome ,0302 clinical medicine ,Predictive Value of Tests ,Risk Factors ,Internal medicine ,medicine ,Diseases of the circulatory (Cardiovascular) system ,Humans ,030304 developmental biology ,Angiology ,Aged ,EWAS ,0303 health sciences ,DNA methylation ,Receiver operating characteristic ,business.industry ,Research ,Area under the curve ,Anatomical structure homeostasis ,Middle Aged ,CVD ,Cardiovascular Diseases ,RC666-701 ,Case-Control Studies ,Cohort ,CpG Islands ,Female ,Cardiology and Cardiovascular Medicine ,business ,Genome-Wide Association Study - Abstract
Background Systemic studies of association of genome-wide DNA methylated sites with cardiovascular disease (CVD) in prospective cohorts are lacking. Our aim was to identify DNA methylation sites associated with the risk of CVD and further investigate their potential predictive value in CVD development for high-risk subjects. Methods We performed an epigenome-wide association study (EWAS) to identify CpGs related to CVD development in a Chinese population.We adopted a nested case–control design based on data from China PEACE Million Persons Project. A total of 83 cases who developed CVD events during follow-up and 83 controls who were matched with cases by age, sex, BMI, ethnicity, medications treatment and behavior risk factors were included in the discovery stage. Genome-wide DNA methylation from whole blood was detected using Infinium Human Methylation EPIC Beadchip (850 K). For significant CpGs [FDR(false discovery rate) Results In discovery set, we identified 8 significant CpGs (FDR UACA) were replicated in another independent set (p p = 9.716E-15]. Conclusions Our study identified the novel CpGs associated with CVD development and revealed their additional predictive power in the risk of CVD for high-risk subjects.
- Published
- 2020
37. Experimental study on splitting strength of sawn lumber loaded perpendicular to grain by bolted steel-wood-steel connections
- Author
-
Bowang Chen, Xin Feng, and Hongbin Xiao
- Subjects
Materials science ,business.industry ,0211 other engineering and technologies ,Fracture mechanics ,Young's modulus ,02 engineering and technology ,Building and Construction ,Structural engineering ,Physics::Classical Physics ,symbols.namesake ,Brittleness ,Mechanics of Materials ,021105 building & construction ,Architecture ,Ultimate tensile strength ,Perpendicular ,symbols ,Physics::Accelerator Physics ,021108 energy ,Wood grain ,Safety, Risk, Reliability and Quality ,business ,Material properties ,Beam (structure) ,Civil and Structural Engineering - Abstract
Connections in timber beams loaded perpendicular to the wood grain are prone to brittle splitting failure. Different approaches can be found in the literature and design codes to account for the splitting capacity in the design of the structure. To study the splitting strength of timber beams loaded perpendicular to the wood grain by bolted steel-wood-steel connections, a total of 240 larch timber beams were tested. The impacts of the diameter of bolts, the number of bolts, the relative connection height, the beam span, and multiple connections of simply supported beams and continuous beams as well as the connection locations with respect to simply supported beams and overhanging beams on the splitting capacity, were investigated. Material properties such as the perpendicular-to-grain tensile strength , modulus of elasticity parallel to the wood grain, and Mode I fracture energy of the tested beams were also evaluated. Based on the comparisons between the test results and the predictions of different approaches for timber beams loaded perpendicular to the wood grain using bolted steel-wood-steel connections, the prediction ability of different approaches was analyzed and recommendations for the approach modification were given.
- Published
- 2021
- Full Text
- View/download PDF
38. Timber harvest planning with spatial objectives, using the method of simulated annealing
- Author
-
BoWang, Chen and v. Gadow, Klaus
- Published
- 2002
- Full Text
- View/download PDF
39. Genetic Imbalance in Patients with Cervical Artery Dissection
- Author
-
Caspar Grond-Ginsbach, Bowang Chen, Michael Krawczak, Rastislav Pjontek, Philip Ginsbach, Yanxiang Jiang, Sherine Abboud, Marie-Luise Arnold, Anna Bersano, Tobias Brandt, Valeria Caso, Stephanie Debette, Martin Dichgans, Andreas Geschwendtner, Giacomo Giacalone, Juan-Jose Martin, Antti Metso, Tiina Metso, Armin Grau, Manja Kloss, Christoph Lichy, Alessandro Pezzini, Christopher Traenka, Stefan Schreiber, Vincent Thijs, Emmanuel Touze, Elisabetta Zotto, Turgut Tatlisumak, Didier Leys, Philippe Lyrer, Stefan Engelter, and Bentham Science Publisher for the CADISP group
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Cervical Artery ,030105 genetics & heredity ,Cervical artery dissection ,Article ,03 medical and health sciences ,0302 clinical medicine ,Genetic imbalance ,Internal medicine ,Genetics ,medicine ,Copy-number variation ,Stroke ,Genetics (clinical) ,Copy number variation ,business.industry ,Odds ratio ,medicine.disease ,Confidence interval ,3. Good health ,Cardiovascular system development ,Rare genetic variation ,Dissection ,Etiology ,business ,030217 neurology & neurosurgery - Abstract
Background: Genetic and environmental risk factors are assumed to contribute to the susceptibility to cervical artery dissection (CeAD). To explore the role of genetic imbalance in the etiology of CeAD, copy number variants (CNVs) were identified in high-density microarrays samples from the multicenter CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) study and from control subjects from the CADISP study and the German PopGen biobank. Microarray data from 833 CeAD patients and 2040 control subjects (565 subjects with ischemic stroke due to causes different from CeAD and 1475 disease-free individuals) were analyzed. Rare genic CNVs were equally frequent in CeAD-patients (16.4%; n=137) and in control subjects (17.0%; n=346) but differed with respect to their genetic content. Compared to control subjects, CNVs from CeAD patients were enriched for genes associated with muscle organ development and cell differentiation, which suggests a possible association with arterial development. CNVs affecting cardiovascular system development were more common in CeAD patients than in control subjects (p=0.003; odds ratio (OR) =2.5; 95% confidence interval (95% CI) =1.4-4.5) and more common in patients with a familial history of CeAD than in those with sporadic CeAD (p=0.036; OR=11.2; 95% CI=1.2-107). Conclusion: The findings suggest that rare genetic imbalance affecting cardiovascular system development may contribute to the risk of CeAD. Validation of these findings in independent study populations is warranted.
- Published
- 2017
- Full Text
- View/download PDF
40. Patient stratification of clear cell renal cell carcinoma using the global transcription factor activity landscape derived from RNA-seq data
- Author
-
Yanyan Zhu, Shundong Cang, Bowang Chen, Yue Gu, Miaomiao Jiang, Junya Yan, Fengmin Shao, and Xiaoyun Huang
- Subjects
Cancer Research ,Systems biology ,Systems Biology ,ccRCC ,RNA-Seq ,Biology ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Precision medicine ,medicine.disease_cause ,lcsh:RC254-282 ,personalized oncology ,Biological pathway ,Clear cell renal cell carcinoma ,Downregulation and upregulation ,Oncology ,medicine ,Cancer research ,Carcinogenesis ,Kidney cancer ,Transcription factor ,transcription factor ,Original Research - Abstract
Clear cell renal cell carcinoma represents the most common type of kidney cancer. Precision medicine approach to ccRCC requires an accurate stratification of patients that can predict prognosis and guide therapeutic decision. Transcription factors are implicated in the initiation and progression of human carcinogenesis. However, no comprehensive analysis of transcription factor activity has been proposed so far to realize patient stratification. Here we propose a novel approach to determine the subtypes of ccRCC patients based on global transcription factor activity landscape. Using the TCGA cohort dataset, we identified different subtypes that have distinct upregulated biomarkers and altered biological pathways. More important, this subtype information can be used to predict the overall survival of ccRCC patients. Our results suggest that transcription factor activity can be harnessed to perform patient stratification.
- Published
- 2019
- Full Text
- View/download PDF
41. Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
- Author
-
Annette Juul Vangsted, van, Duin, M, David E. Neal, Peter Hoffmann, A Wolk, Robert J. Hamilton, Anthony J. Swerdlow, F. Wiklund, De, Ruyck, K, Paul A. Townsend, S. N. Thibodeau, Asta Försti, Esther M. John, Unnur Thorsteinsdottir, W Gregory, Niels Frost Andersen, Peter Broderick, A-K Wihlborg, Frank Claessens, Doug Easton, Kathryn L. Penney, Keith W. Muir, Jeri Kim, Jonathan S. Mitchell, Johanna Schleutker, G Cancel-Tassin, Barry S. Rosenstein, Jy Park, Hauke Thomsen, Rowan Kuiper, C West, H Gronberg, Mina Ali, CM Tangen, Obul Reddy Bandapalli, Ana Vega, Faith E. Davies, Rosalind A. Eeles, Daniel F. Gudbjartsson, Fredrick R. Schumacher, Janet L. Stanford, Paul D.P. Pharoah, Owen W. Stephens, Monique J. Roobol, Richard S. Houlston, Gudmar Thorleifsson, Christian Langer, Susan L. Neuhausen, S Chanock, G.G. Giles, Azad Razack, S Koutros, F Canzian, S Benlloch, H. Einsele, Kari Hemminki, KD Sorensen, Y-J Lu, K-T Khaw, Hareth Nahi, FC Hamdy, D Albanes, Christopher A. Haiman, Ellinor Johnsson, Amit Sud, Adam S. Kibel, Pieter Sonneveld, Florence Menegaux, Manolis Kogevinas, Nawaid Usmani, Annemiek Broyl, K. H. Jöckel, Jolanta Nickel, David W. Johnson, Aaa Olama, B.G. Nordestgaard, Amy Holroyd, Niels Weinhold, Cezary Cybulski, Sigurdur Y. Kristinsson, Radka Kaneva, Ruth C. Travis, Kari Stefansson, SI Berndt, Bowang Chen, Scott Kimber, Davor Lessel, Philip J. Law, M. M. Nöthen, Lisa A. Cannon-Albright, BE Henderson, Ni Li, Urban Gullberg, Uta Bertsch, S Weinstein, Nora Pashayan, Christiane Maier, H Brenner, Ingemar Turesson, Hardev Pandha, Thorunn Rafnar, Alison M. Dunning, Fiona M. Ross, Graham Jackson, David V. Conti, Sue A. Ingles, da, Silva, Filho, Mi, Jens Hillengass, Lisa F. Newcomb, Giulia Orlando, Brian A Walker, Teixeira, Björn Nilsson, Jenny L Donovan, Molly Went, U. H. Mellqvist, Chiara Campo, Zsofia Kote-Jarai, VL Stevens, Martin Kaiser, B-M Halvarsson, J Clements, Martin Hansson, Manuela Gago-Dominguez, EM Grindedal, Anders Waage, Julian Peto, L Mucci, Gareth J. Morgan, J Batra, and H. Goldschmidt
- Subjects
Male ,Quality Control ,Risk ,0301 basic medicine ,Chromatin Immunoprecipitation ,Genotype ,Computer science ,Science ,Quantitative Trait Loci ,Medizin ,General Physics and Astronomy ,Genome-wide association study ,02 engineering and technology ,computer.software_genre ,Polymorphism, Single Nucleotide ,White People ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Humans ,Genetic Predisposition to Disease ,lcsh:Science ,Author Correction ,Promoter Regions, Genetic ,Multidisciplinary ,business.industry ,Bayes Theorem ,General Chemistry ,021001 nanoscience & nanotechnology ,Chromatin ,Spelling ,Identification (information) ,030104 developmental biology ,Gene Expression Regulation ,Cancer genetics ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,lcsh:Q ,Female ,Artificial intelligence ,Multiple Myeloma ,0210 nano-technology ,business ,computer ,Natural language processing ,Genome-Wide Association Study - Abstract
Genome-wide association studies (GWAS) have transformed our understanding of susceptibility to multiple myeloma (MM), but much of the heritability remains unexplained. We report a new GWAS, a meta-analysis with previous GWAS and a replication series, totalling 9974 MM cases and 247,556 controls of European ancestry. Collectively, these data provide evidence for six new MM risk loci, bringing the total number to 23. Integration of information from gene expression, epigenetic profiling and in situ Hi-C data for the 23 risk loci implicate disruption of developmental transcriptional regulators as a basis of MM susceptibility, compatible with altered B-cell differentiation as a key mechanism. Dysregulation of autophagy/apoptosis and cell cycle signalling feature as recurrently perturbed pathways. Our findings provide further insight into the biological basis of MM.
- Published
- 2019
- Full Text
- View/download PDF
42. Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study
- Author
-
Haibo Zhang, Bowang Chen, Lanxia Gan, Zhiye Zhou, Jiapeng Lu, Haibo Wang, Xueke Bai, Xi Li, Ying Shi, Shuang Hu, Qing Wang, Lihua Zhang, Jiamin Liu, Xiaoyan Zhang, Xin Zheng, and Jing Li
- Subjects
Male ,Qingfei Paidu Tang ,Pharmaceutical Science ,0302 clinical medicine ,Interquartile range ,Drug Discovery ,Medicine ,Hospital Mortality ,Registries ,Medicine, Chinese Traditional ,QPT, Qingfei Paidu Tang ,0303 health sciences ,Incidence ,Incidence (epidemiology) ,Medical record ,Hazard ratio ,OR, odds ratios ,HR, hazard ratios ,Acute Kidney Injury ,Middle Aged ,IPTW, inverse probability treatment weighting ,SMD, standard mean difference ,COVID-19, Coronavirus Disease 2019 ,030220 oncology & carcinogenesis ,Molecular Medicine ,Female ,Original Article ,Chemical and Drug Induced Liver Injury ,Adult ,China ,medicine.medical_specialty ,Lower risk ,03 medical and health sciences ,Internal medicine ,Humans ,Mortality ,IQR, interquartile range ,Aged ,Proportional Hazards Models ,Retrospective Studies ,030304 developmental biology ,Pharmacology ,business.industry ,Proportional hazards model ,COVID-19 ,Retrospective cohort study ,Odds ratio ,Confidence interval ,COVID-19 Drug Treatment ,CI, confidence interval ,Complementary and alternative medicine ,Propensity score matching ,business ,Drugs, Chinese Herbal - Abstract
Background : Qingfei Paidu Tang (QPT), a formula of traditional Chinese medicine, which was suggested to be able to ease symptoms in patients with Coronavirus Disease 2019 (COVID-19), has been recommended by clinical guidelines and widely used to treat COVID-19 in China. However, whether it decreases mortality remains unknown. Purpose : We aimed to explore the association between QPT use and in-hospital mortality among patients hospitalized for COVID-19. Study design : A retrospective study based on a real-world database was conducted. Methods : We identified patients consecutively hospitalized with COVID-19 in 15 hospitals from a national retrospective registry in China, from January through May 2020. Data on patients’ characteristics, treatments, and outcomes were extracted from the electronic medical records. The association of QPT use with COVID-19 related mortality was evaluated using Cox proportional hazards models based on propensity score analysis. Results : Of the 8939 patients included, 28.7% received QPT. The COVID-19 related mortality was 1.2% (95% confidence interval [CI] 0.8% to 1.7%) among the patients receiving QPT and 4.8% (95% CI 4.3% to 5.3%) among those not receiving QPT. After adjustment for patient characteristics and concomitant treatments, QPT use was associated with a relative reduction of 50% in in-hospital COVID-19 related mortality (hazard ratio, 0.50; 95% CI, 0.37 to 0.66 P, Graphical abstract Image, graphical abstract
- Published
- 2021
- Full Text
- View/download PDF
43. Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014-2018.
- Author
-
Lin Mu, Jiamin Liu, Guohai Zhou, Chaoqun Wu, Bowang Chen, Yuan Lu, Jiapeng Lu, Xiaofang Yan, Zhihong Zhu, Nasir, Khurram, Spatz, Erica S., Krumholz, Harlan M., Xin Zheng, Mu, Lin, Liu, Jiamin, Zhou, Guohai, Wu, Chaoqun, Chen, Bowang, Lu, Yuan, and Lu, Jiapeng
- Subjects
OBESITY ,RESEARCH ,CROSS-sectional method ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,WAIST circumference ,DISEASE prevalence ,RESEARCH funding ,BODY mass index - Abstract
Background: China has seen a burgeoning epidemic of obesity in recent decades, but few studies reported nationally on obesity across socio-demographic subgroups. We sought to assess the prevalence and socio-demographic associations of obesity nationwide.Methods: We assessed the prevalence of overall obesity (body mass index ≥28 kg/m2) and abdominal obesity (waist circumference ≥85/90 cm for women/men) among 2.7 million community-dwelling adults aged 35 to 75 years in the China PEACE Million Persons Project from 2014 to 2018 and quantified the socio-demographic associations of obesity using multivariable mixed models.Results: Age-standardized rates of overall and abdominal obesity were 14.4% (95% CI, 14.3%-14.4%) and 32.7% (32.6%-32.8%) in women and 16.0% (15.9%-16.1%) and 36.6% (36.5%-36.8%) in men. Obesity varied considerably across socio-demographic subgroups. Older women were at higher risk for obesity (eg, adjusted relative risk [95% CI] of women aged 65-75 versus 35-44 years: 1.29 [1.27-1.31] for overall obesity, 1.76 [1.74-1.77] for abdominal obesity) while older men were not. Higher education was associated with lower risk in women (eg, adjusted relative risk [95% CI] of those with college or university education versus below primary school: 0.47 [0.46-0.48] for overall obesity, 0.61 [0.60-0.62] for abdominal obesity) but higher risk in men (1.07 [1.05-1.10], 1.17 [1.16-1.19]).Conclusions: In China, over 1 in 7 individuals meet criteria for overall obesity, and 1 in 3 for abdominal obesity. Wide variation exists across socio-demographic subgroups. The associations of age and education with obesity are significant and differ by sex. Understanding obesity in contemporary China has broad domestic policy implications and provides a valuable international reference. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
44. Copy Number Variation and Risk of Stroke
- Author
-
Philipp Erhart, Stefan T. Engelter, John W. Cole, Caspar Grond-Ginsbach, Bowang Chen, and Manja Kloss
- Subjects
0301 basic medicine ,DNA Copy Number Variations ,MEDLINE ,Genomics ,Genome ,Polymorphism, Single Nucleotide ,Article ,03 medical and health sciences ,Polymorphism (computer science) ,Medicine ,Humans ,Genetic Predisposition to Disease ,Copy-number variation ,Stroke ,Oligonucleotide Array Sequence Analysis ,Advanced and Specialized Nursing ,Genetics ,business.industry ,Genome, Human ,medicine.disease ,Human genetics ,030104 developmental biology ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,business ,Comparative genomic hybridization - Published
- 2018
45. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer
- Author
-
Yi Lei, Bowang Chen, Weimin Li, Jiaxin Gong, Wang Guo, and Lu Chen
- Subjects
0301 basic medicine ,Cancer Research ,Lung Neoplasms ,Cell ,Antineoplastic Agents ,Exosomes ,03 medical and health sciences ,0302 clinical medicine ,Gefitinib ,Microscopy, Electron, Transmission ,Carcinoma, Non-Small-Cell Lung ,Cell Line, Tumor ,Heterogeneous-Nuclear Ribonucleoprotein Group A-B ,medicine ,exosome ,Humans ,skin and connective tissue diseases ,neoplasms ,non-small cell lung cancer ,gefitinib resistance ,Cell Proliferation ,Oncogene ,H19 ,Cell growth ,Chemistry ,General Medicine ,Articles ,Cell cycle ,Microvesicles ,female genital diseases and pregnancy complications ,respiratory tract diseases ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,Cell culture ,Drug Resistance, Neoplasm ,030220 oncology & carcinogenesis ,Gene Knockdown Techniques ,embryonic structures ,Cancer research ,RNA, Long Noncoding ,Tyrosine kinase ,medicine.drug - Abstract
Currently, resistance to tyrosine kinase inhibitors, such as gefitinib, has become one major obstacle for improving the clinical outcome of patients with metastatic and advanced‑stage non‑small cell lung cancer (NSCLC). While cell behavior can be modulated by long non‑coding RNAs (lncRNAs), the contributions of lncRNAs within extracellular vesicles (exosomes) are largely unknown. To this end, the involvement and regulatory functions of lncRNA H19 wrapped by exosomes during formation of gefitinib resistance in human NSCLC were investigated. Gefitinib‑resistant cell lines were built by continuously grafting HCC827 and HCC4006 cells into gefitinib‑contained culture medium. RT‑qPCR assays indicated that H19 was increased in gefitinib‑resistant cells when compared to sensitive parent cells. Functional experiments revealed that silencing of H19 potently promoted gefitinib‑induced cell cytotoxicity. H19 was secreted by packaging into exosomes and this packaging process was specifically mediated by hnRNPA2B1. H19 wrapped in exosomes could be transferred to non‑resistant cells, thus inducing gefitinib resistance. Moreover, treatment‑sensitive cells with exosomes highly‑expressing H19 induced gefitinib resistance, while knockdown of H19 abrogated this effect. In conclusion, H19 promoted gefitinib resistance of NSCLC cells by packaging into exosomes. Therefore, exosomal H19 may be a promising therapeutic target for EGFR+ NSCLC patients.
- Published
- 2018
46. Relevance Study of Translation Process
- Author
-
Minhua Dong and Bowang Chen
- Subjects
business.industry ,Process (engineering) ,Computer science ,Translation (biology) ,Relevance (information retrieval) ,Artificial intelligence ,computer.software_genre ,business ,computer ,Natural language processing - Published
- 2018
- Full Text
- View/download PDF
47. Departure from Hardy Weinberg Equilibrium and Genotyping Error
- Author
-
John W. Cole, Caspar Grond-Ginsbach, and Bowang Chen
- Subjects
0301 basic medicine ,lcsh:QH426-470 ,Population ,Single-nucleotide polymorphism ,Biology ,Loss of heterozygosity ,03 medical and health sciences ,0302 clinical medicine ,Genetics ,heterozygosity ,Copy-number variation ,Hardy Weinberg Equilibrium (HWE) ,education ,Exome ,Genotyping ,Genetics (clinical) ,Original Research ,education.field_of_study ,Hardy–Weinberg principle ,SNP quality control ,lcsh:Genetics ,030104 developmental biology ,association studies in genetics ,Molecular Medicine ,Inbreeding ,030217 neurology & neurosurgery - Abstract
Objective: Departure from Hardy Weinberg Equilibrium (HWE) may occur due to a variety of causes, including purifying selection, inbreeding, population substructure, copy number variation or genotyping error. We searched for specific characteristics of HWE-departure due to genotyping error.Methods: Genotypes of a random set of genetic variants were obtained from the Exome Aggregation Consortium (ExAC) database. Variants with 98%, LoH d-HWE was found in 29 (1.3%) variants, but no GoH d-HWE was detected. The findings of the non-random distribution of HWE-violating SNPs along the chromosome, the association with common deletion polymorphisms and indel-variant type, and the finding of excess heterozygotes in genomic regions that are prone to cross-hybridization were confirmed in a large sample of short variants from the 1,000 Genomes Project.Conclusions: We differentiated between two types of HWE-departure. GoH d-HWE was suggestive for genotyping error. LoH d-HWE, on the contrary, pointed to natural variabilities such as population substructure or common deletion polymorphisms.
- Published
- 2017
- Full Text
- View/download PDF
48. Novel Genome-Wide Association Study–Based Candidate Loci for Differentiated Thyroid Cancer Risk
- Author
-
Ricard Marcos, Michał Kalemba, Aleksandra Köhler, Stefan Herms, Rossella Elisei, Franco Bambi, Monica Cipollini, Susana Pastor, Cristina Romei, Gisella Figlioli, Barbara Jarząb, Kari Hemminki, Dorota Kula, Elisa Paolicchi, Alfonso Cristaudo, Stefano Landi, Antonia Velázquez, Per Hoffmann, Asta Försti, Federica Gemignani, and Bowang Chen
- Subjects
Adult ,Male ,papillary thyroid cancer ,susceptibility ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Context (language use) ,Genome-wide association study ,Single-nucleotide polymorphism ,Biology ,Polymorphism, Single Nucleotide ,Biochemistry ,Papillary thyroid cancer ,Endocrinology ,Risk Factors ,Adenocarcinoma, Follicular ,Prevalence ,medicine ,Adenoma, Oxyphilic ,Humans ,Genetic Predisposition to Disease ,Thyroid Neoplasms ,Thyroid cancer ,Genetic association ,Genetics ,Incidence ,Biochemistry (medical) ,Cell Differentiation ,Odds ratio ,medicine.disease ,Carcinoma, Papillary ,Italy ,Genetic Loci ,Female ,Genome-Wide Association Study ,FOXE1 - Abstract
Genome-wide association studies (GWASs) on differentiated thyroid cancer (DTC) have identified robust associations with single nucleotide polymorphisms (SNPs) at 9q22.33 (FOXE1), 14q13.3 (NKX2-1), and 2q35 (DIRC3). Our recently published GWAS suggested additional susceptibility loci specific for the high-incidence Italian population.The purpose of this study was to identify novel Italian-specific DTC risk variants based on our GWAS and to test them further in low-incidence populations.We investigated 45 SNPs selected from our GWAS first in an Italian population. SNPs that showed suggestive evidence of association were investigated in the Polish and Spanish cohorts.The combined analysis of the GWAS and the Italian replication study (2260 case patients and 2218 control subjects) provided strong evidence of association with rs10136427 near BATF (odds ratio [OR] =1.40, P = 4.35 × 10(-7)) and rs7267944 near DHX35 (OR = 1.39, P = 2.13 × 10(-8)). A possible role in DTC susceptibility in the Italian populations was also found for rs13184587 (ARSB) (P = 8.54 × 10(-6)) and rs1220597 (SPATA13) (P = 3.25 × 10(-6)). Only the associations between rs10136427 and rs7267944 and DTC risk were replicated in the Polish and the Spanish populations with little evidence of population heterogeneity (GWAS and all replications combined, OR = 1.30, P = 9.30 × 10(-7) and OR = 1.32, P = 1.34 × 10(-8), respectively). In silico analyses provided new insights into the possible functional consequences of the SNPs that showed the strongest association with DTC.Our findings provide evidence for novel DTC susceptibility variants. Further studies are warranted to identify the specific genetic variants responsible for the observed associations and to functionally validate our in silico predictions.
- Published
- 2014
- Full Text
- View/download PDF
49. Copy Number Studies in Noisy Samples
- Author
-
Stefan T. Engelter, Yanxiang Jiang, Bowang Chen, Caspar Grond-Ginsbach, and Philip Ginsbach
- Subjects
noise reduction ,genetic structures ,Computer science ,Noise reduction ,Biomedical Engineering ,Bioengineering ,variance ,Bioinformatics ,Biochemistry ,Article ,eye diseases ,lcsh:Biochemistry ,Clinical study ,Noise ,copy number variation (CNV) ,per-SNP noise ,wave noise ,noise-free-cnv software ,validation of CNV findings ,Statistics ,lcsh:QD415-436 ,Copy-number variation ,Biotechnology - Abstract
System noise was analyzed in 77 Affymetrix 6.0 samples from a previous clinical study of copy number variation (CNV). Twenty-three samples were classified as eligible for CNV detection, 29 samples as ineligible and 25 were classified as being of intermediate quality. New software (“noise-free-cnv”) was developed to visualize the data and reduce system noise. Fresh DNA preparations were more likely to yield eligible samples (p < 0.001). Eligible samples had higher rates of successfully genotyped SNPs (p < 0.001) and lower variance of signal intensities (p < 0.001), yielded fewer CNV findings after Birdview analysis (p < 0.001), and showed a tendency to yield fewer PennCNV calls (p = 0.053). The noise-free-cnv software visualized trend patterns of noise in the signal intensities across the ordered SNPs, including a wave pattern of noise, being co-linear with the banding pattern of metaphase chromosomes, as well as system deviations of individual probe sets (per-SNP noise). Wave noise and per-SNP noise occurred independently and could be separately removed from the samples. We recommend a two-step procedure of CNV validation, including noise reduction and visual inspection of all CNV calls, prior to molecular validation of a selected number of putative CNVs.
- Published
- 2013
- Full Text
- View/download PDF
50. Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3
- Author
-
Witigo von Schönfels, Jesus Lascorz Puertolas, Kari Hemminki, Reinhard Büttner, Sarah Stöcker, Bowang Chen, Brigitte Royer-Pokora, Rongxi Yang, Matthias Kloor, Michael Krawczak, Clemens Schafmayer, Asta Försti, Peter Bugert, Thomas Becker, Wolff Schmiegel, Barbara Burwinkel, Peter Propping, Hans K. Schackert, Verena Steinke, Katrin Pfütze, Christoph Engel, Stephan Buch, Stefan Schreiber, Jochen Hampe, Nelli Kunkel, and Elke Holinski-Feder
- Subjects
Adult ,Male ,Cancer Research ,Adolescent ,DNA Copy Number Variations ,Genome-wide association study ,Biology ,Polymerase Chain Reaction ,Polymorphism, Single Nucleotide ,GTP Phosphohydrolases ,Structural variation ,Young Adult ,Risk Factors ,Missing heritability problem ,Biomarkers, Tumor ,medicine ,Humans ,Copy-number variation ,Promoter Regions, Genetic ,Aged ,Aged, 80 and over ,Gene Rearrangement ,Genetics ,Chromosomes, Human, Pair 12 ,Genome, Human ,Case-control study ,Cancer ,General Medicine ,Gene rearrangement ,Middle Aged ,medicine.disease ,digestive system diseases ,Case-Control Studies ,Female ,Human genome ,Colorectal Neoplasms ,Genome-Wide Association Study - Abstract
Colorectal cancer (CRC) is one of the most common cancer worldwide. However, a large number of genetic risk factors involved in CRC have not been understood. Copy number variations (CNVs) might partly contribute to the 'missing heritability' of CRC. An increased overall burden of CNV has been identified in several complex diseases, whereas the association between the overall CNV burden and CRC risk is largely unknown. We performed a genome-wide investigation of CNVs on genomic DNA from 384 familial CRC cases and 1285 healthy controls by the Affymetrix 6.0 array. An increase of overall CNV burden was observed in familial CRC patients compared with healthy controls, especially for CNVs larger than 50kb (case/control ratio = 1.66, P = 0.025). In addition, we discovered for the first time a novel structural variation at 12p12.3 and determined the breakpoints by strategic PCR and sequencing. This 12p12.3 structural variation was found in four of 2862 CRC cases but not in 6243 healthy controls (P = 0.0098). RERGL gene (RERG/RAS-like), the only gene influenced by the 12p12.3 structural variation, sharing most of the conserved regions with its close family member RERG tumor suppressor gene (RAS-like, estrogen-regulated, growth inhibitor), might be a novel CRC-related gene. In conclusion, this is the first study to reveal the contribution of the overall burden of CNVs to familial CRC risk and identify a novel rare structural variation at 12p12.3 containing RERGL gene to be associated with CRC.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.